{
  "meta": {
    "id": "test4",
    "title": "Gastroenterology",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following clinical features is most indicative of advanced cirrhosis with portal hypertension?",
      "options": [
        {
          "label": "A",
          "text": "Jaundice",
          "correct": false
        },
        {
          "label": "B",
          "text": "Easy bruising",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spider nevi",
          "correct": false
        },
        {
          "label": "D",
          "text": "Caput medusae",
          "correct": true
        }
      ],
      "correct_answer": "D. Caput medusae",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-140329.png"
      ],
      "explanation": "<p><strong>Ans. D) Caput medusae</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Jaundice: Jaundice is a sign of liver dysfunction but is not specific to portal hypertension.</li><li>\u2022 Option A. Jaundice:</li><li>\u2022 Option B. Easy bruising: Easy bruising can indicate liver dysfunction due to decreased production of clotting factors but, like jaundice, is not specific to portal hypertension.</li><li>\u2022 Option B. Easy bruising:</li><li>\u2022 Option C. Spider nevi: Spider nevi are associated with liver disease but are less specific for portal hypertension compared to caput medusae.</li><li>\u2022 Option C. Spider nevi:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Caput medusae is a clinical feature indicative of portal hypertension in the setting of advanced cirrhosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b48c796f",
      "audio": ""
    },
    {
      "text": "A 62-year-old man with a history of cirrhosis due to chronic hepatitis B infection presents with altered mental status. On examination, he exhibits asterixis. Which of the following best describes this patient's condition?",
      "options": [
        {
          "label": "A",
          "text": "Acute stroke",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatic encephalopathy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Alzheimer's disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal pressure hydrocephalus",
          "correct": false
        }
      ],
      "correct_answer": "B. Hepatic encephalopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Hepatic encephalopathy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Acute stroke: Typically presents with sudden onset neurological deficits such as weakness or numbness on one side of the body, difficulty speaking, or facial drooping, which are not described in this case.</li><li>\u2022 Option A. Acute stroke:</li><li>\u2022 Option C. Alzheimer's disease: Is a progressive neurodegenerative disorder characterized by gradual memory loss, cognitive decline, and changes in behavior, but it does not typically present with acute changes or asterixis.</li><li>\u2022 Option C. Alzheimer's disease:</li><li>\u2022 Option D. Normal pressure hydrocephalus: Is characterized by the triad of gait disturbance, urinary incontinence, and cognitive decline, but the acute onset and presence of asterixis are more indicative of hepatic encephalopathy in the context of known liver disease.</li><li>\u2022 Option D. Normal pressure hydrocephalus:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepatic encephalopathy's characteristic presentation in a patient with underlying liver disease, includes altered mental status, confusion, difficulty with tasks, and asterixis, which highlights liver function in neuropsychiatric status.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "90e80287",
      "audio": ""
    },
    {
      "text": "Which of the following parameters is NOT included in the Child-Turcotte-Pugh (CTP) score to assess the severity of liver disease?",
      "options": [
        {
          "label": "A",
          "text": "Serum albumin level",
          "correct": false
        },
        {
          "label": "B",
          "text": "International normalized ratio (INR)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Serum sodium level",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ascites",
          "correct": false
        }
      ],
      "correct_answer": "C. Serum sodium level",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Serum sodium level</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Serum albumin level: Is included in the CTP score as a measure of the liver's synthetic function.</li><li>\u2022 Option A. Serum albumin level:</li><li>\u2022 Option B. International normalized ratio: INR is included to assess the liver's ability to synthesize clotting factors.</li><li>\u2022 Option B. International normalized ratio:</li><li>\u2022 Option D. Ascites: The presence and severity of ascites are used to evaluate the liver's synthetic function and portal hypertension.</li><li>\u2022 Option D. Ascites:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 To recognize the components of the Child-Turcotte-Pugh score and understand that serum sodium level is not included in this assessment of liver disease severity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9874f38",
      "audio": ""
    },
    {
      "text": "A patient with chronic liver disease has a Child-Pugh score of 8. Which Child-Pugh class does this score fall into?",
      "options": [
        {
          "label": "A",
          "text": "Child-Pugh class A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Child-Pugh class B",
          "correct": true
        },
        {
          "label": "C",
          "text": "Child-Pugh class C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Child-Pugh class D",
          "correct": false
        }
      ],
      "correct_answer": "B. Child-Pugh class B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Child-Pugh class A: Is for scores of 5-6, representing mild liver disease.</li><li>\u2022 Option A. Child-Pugh class A:</li><li>\u2022 Option C.  Child-Pugh class C: Is for scores of 10-15, representing severe liver disease.</li><li>\u2022 Option C.  Child-Pugh class C:</li><li>\u2022 Option D. Child-Pugh class D: There is no Child-Pugh class D in the classification system.</li><li>\u2022 Option D.</li><li>\u2022 Child-Pugh class D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Child-Pugh score of 8 categorizes a patient with chronic liver disease into Class B, indicating moderate severity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a03bb30",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate pharmacological treatment to add for persistent ascites in cirrhotic patients after dietary sodium restriction ?",
      "options": [
        {
          "label": "A",
          "text": "Oral spironolactone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intravenous albumin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral antibiotics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonselective beta-blockers",
          "correct": false
        }
      ],
      "correct_answer": "A. Oral spironolactone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Oral spironolactone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Intravenous albumin: Intravenous albumin is used primarily in the management of large-volume paracentesis or in specific cases like spontaneous bacterial peritonitis, not as a first-line treatment for moderate ascites.</li><li>\u2022 Option B. Intravenous albumin:</li><li>\u2022 Option C. Oral antibiotics: Oral antibiotics are used for the treatment or prevention of spontaneous bacterial peritonitis, not for the direct management of ascites.</li><li>\u2022 Option C. Oral antibiotics:</li><li>\u2022 Option D. Nonselective beta-blockers: Nonselective beta-blockers are used for variceal bleeding prophylaxis and can worsen ascites in some cirrhotic patients by reducing renal perfusion.</li><li>\u2022 Option D. Nonselective beta-blockers:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Oral spironolactone is the first-line pharmacological treatment for cirrhotic patients with persistent ascites despite dietary sodium restriction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b769f67",
      "audio": ""
    },
    {
      "text": "A 47-year-old male with known cirrhosis presents to the emergency department with hematemesis. He is hypotensive and tachycardic. After initial resuscitation with IV fluids, what is the most appropriate next step in the management of suspected variceal bleeding?",
      "options": [
        {
          "label": "A",
          "text": "Oral proton pump inhibitors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endoscopic band ligation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intravenous octreotide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Immediate liver transplantation",
          "correct": false
        }
      ],
      "correct_answer": "C. Intravenous octreotide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Intravenous octreotide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Oral proton pump inhibitors: Oral proton pump inhibitors are used in the management of peptic ulcer disease bleeding, not variceal bleeding.</li><li>\u2022 Option A. Oral proton pump inhibitors:</li><li>\u2022 Option B. Endoscopic band ligation: Endoscopic band ligation is a definitive treatment for variceal bleeding but may not be immediately available and should be preceded by pharmacological therapy to control the bleeding.</li><li>\u2022 Option B. Endoscopic band ligation:</li><li>\u2022 Option D. Immediate liver transplantation: Immediate liver transplantation is not a practical immediate step in the acute management of variceal bleeding.</li><li>\u2022 Option D. Immediate liver transplantation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Intravenous octreotide is a critical component of the initial management of acute variceal bleeding in cirrhotic patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7c704c8",
      "audio": ""
    },
    {
      "text": "Child-Pugh score of 8 comes under ?",
      "options": [
        {
          "label": "A",
          "text": "Child-Pugh class A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Child-Pugh class B",
          "correct": true
        },
        {
          "label": "C",
          "text": "Child-Pugh class C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Child-Pugh class D",
          "correct": false
        }
      ],
      "correct_answer": "B. Child-Pugh class B",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Child-Pugh class B</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "74b0fe28",
      "audio": ""
    },
    {
      "text": "A 68-year-old man who recently underwent total knee replacement surgery presents with sudden onset of shortness of breath and pleuritic chest pain. His ECG shows sinus tachycardia and the D-dimer test is elevated. Which of the following is the most appropriate next step in diagnosing this patient?",
      "options": [
        {
          "label": "A",
          "text": "Arterial blood gas analysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary function tests",
          "correct": false
        },
        {
          "label": "C",
          "text": "Computed tomography pulmonary angiography (CTPA)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transthoracic echocardiogram",
          "correct": false
        }
      ],
      "correct_answer": "C. Computed tomography pulmonary angiography (CTPA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Arterial blood gas analysis: Arterial blood gas analysis can show hypoxemia and hypocapnia in the case of PE, but these findings are nonspecific and cannot confirm the diagnosis.</li><li>\u2022 Option A. Arterial blood gas analysis:</li><li>\u2022 Option B. Pulmonary function tests: Pulmonary function tests are not useful in the acute setting of suspected PE as they are primarily used to evaluate chronic respiratory conditions.</li><li>\u2022 Option B. Pulmonary function tests:</li><li>\u2022 Option D. Transthoracic Echocardiogram: A transthoracic echocardiogram can be helpful in assessing right ventricular function in the setting of PE and may show signs of right heart strain, but it cannot diagnose PE directly. It is more useful in risk stratification and management rather than initial diagnosis.</li><li>\u2022 Option D. Transthoracic Echocardiogram:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The computed tomography pulmonary angiography (CTPA) is the most appropriate diagnostic test for a patient with suspected pulmonary embolism, especially in the context of recent surgery and elevated D-dimer levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "18eaf21c",
      "audio": ""
    },
    {
      "text": "A 72-year-old woman with a history of chronic obstructive pulmonary disease (COPD) presents to the clinic with increased shortness of breath, wheezing, and productive cough for the past 2 days. She uses a short-acting bronchodilator as needed. Which of the following is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Start systemic corticosteroids",
          "correct": true
        },
        {
          "label": "B",
          "text": "Prescribe a long-acting muscarinic antagonist",
          "correct": false
        },
        {
          "label": "C",
          "text": "Initiate antibiotic therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase the dose of the short-acting bronchodilator",
          "correct": false
        }
      ],
      "correct_answer": "A. Start systemic corticosteroids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Prescribing a long-acting muscarinic antagonist: Prescribing a long-acting muscarinic antagonist (LAMA) is a good option for long-term management of COPD to improve symptoms and reduce exacerbations, but it is not the first choice for treating an acute exacerbation.</li><li>\u2022 Option B. Prescribing a long-acting muscarinic antagonist:</li><li>\u2022 Option C. Initiate antibiotic therapy: Antibiotic therapy may be indicated if there is a strong suspicion or evidence of a bacterial infection contributing to the exacerbation, such as increased sputum purulence, but it is not the standard initial treatment for all acute COPD exacerbations.</li><li>\u2022 Option C. Initiate antibiotic therapy:</li><li>\u2022 Option D. Increase the dose of the short-acting bronchodilator: Increasing the dose of a short-acting bronchodilator can provide symptomatic relief and is often part of the management of acute exacerbations, but it may not be sufficient on its own without addressing the inflammation with corticosteroids.</li><li>\u2022 Option D. Increase the dose of the short-acting bronchodilator:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Systemic corticosteroids are an appropriate initial treatment for an acute exacerbation of COPD, as they address the underlying airway inflammation and can improve symptoms and lung function.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a0cb2867",
      "audio": ""
    },
    {
      "text": "A 34-year-old man is brought to the emergency department after a motor vehicle accident. He is tachypneic, hypotensive, and has decreased breath sounds on the left side with tracheal deviation to the right. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hemothorax",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rib fracture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tension pneumothorax",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pulmonary contusion",
          "correct": false
        }
      ],
      "correct_answer": "C. Tension pneumothorax",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tension pneumothorax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hemothorax: Hemothorax involves the accumulation of blood in the pleural space and can present with similar symptoms, but tracheal deviation is more specifically associated with tension pneumothorax due to the significant shift in mediastinal structures.</li><li>\u2022 Option A. Hemothorax:</li><li>\u2022 Option B. Rib fractures: Rib fractures can cause pain and lead to shallow breathing, potentially causing or contributing to a pneumothorax, but the clinical presentation described is more consistent with a tension pneumothorax.</li><li>\u2022 Option B. Rib fractures:</li><li>\u2022 Option D. Pulmonary contusion: Pulmonary contusion involves injury to the lung tissue itself and can lead to respiratory distress, but it does not cause tracheal deviation.</li><li>\u2022 Option D. Pulmonary contusion:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical presentation of a tension pneumothorax, includes tachypnea, hypotension, decreased breath sounds on the affected side, and contralateral tracheal deviation, as a life-threatening condition that requires immediate intervention.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b5048f4f",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate diagnostic test to confirm cirrhosis in a patient?",
      "options": [
        {
          "label": "A",
          "text": "Abdominal ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liver biopsy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Serum albumin level",
          "correct": false
        },
        {
          "label": "D",
          "text": "Upper gastrointestinal endoscopy",
          "correct": false
        }
      ],
      "correct_answer": "B. Liver biopsy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Liver biopsy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Abdominal ultrasound: Can suggest cirrhosis by showing a nodular liver surface, ascites, or signs of portal hypertension but cannot definitively diagnose cirrhosis.</li><li>\u2022 Option A. Abdominal ultrasound:</li><li>\u2022 Option C. Serum albumin level: Can indicate liver function but is not a diagnostic test for cirrhosis.</li><li>\u2022 Option C. Serum albumin level:</li><li>\u2022 Option D. Upper gastrointestinal endoscopy: Is useful for identifying complications of portal hypertension such as esophageal varices, not for diagnosing cirrhosis itself.</li><li>\u2022 Option D. Upper gastrointestinal endoscopy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Liver biopsy is the gold standard diagnostic test for confirming cirrhosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "040cdad4",
      "audio": ""
    },
    {
      "text": "A 57-year-old woman with end-stage liver disease is being evaluated for liver transplantation. Her recent laboratory tests include serum bilirubin, serum creatinine, and INR. Which additional parameter is essential to calculate her Model for End-Stage Liver Disease (MELD) score?",
      "options": [
        {
          "label": "A",
          "text": "Serum albumin level",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serum sodium level",
          "correct": true
        },
        {
          "label": "C",
          "text": "Platelet count",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hemoglobin level",
          "correct": false
        }
      ],
      "correct_answer": "B. Serum sodium level",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Serum sodium level</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Serum albumin level: Serum albumin level is not included in the MELD score calculation, although it is an important parameter in assessing liver function and nutritional status.</li><li>\u2022 Option A. Serum albumin level:</li><li>\u2022 Option C. Platelet count: Platelet count is not part of the MELD score calculation but is often used in assessing the degree of portal hypertension and hypersplenism in liver disease patients.</li><li>\u2022 Option C. Platelet count:</li><li>\u2022 Option D. Hemoglobin level: Hemoglobin level is also not included in the MELD score calculation and is not directly related to liver function, although anemia can be a complication of end-stage liver disease.</li><li>\u2022 Option D. Hemoglobin level:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Serum sodium level, in addition to serum bilirubin, serum creatinine, and INR, is essential for calculating the MELD score, which is used to assess the severity and prognosis of end-stage liver disease for transplantation prioritization.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24914322",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a history of alcohol use disorder presents with new-onset ascites. Paracentesis is performed, and the serum-ascites albumin gradient (SAAG) is calculated to be 1.8 g/dL. Which of the following is the most likely cause of his ascites?",
      "options": [
        {
          "label": "A",
          "text": "Tuberculous peritonitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cirrhosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pancreatic ascites",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nephrotic syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Cirrhosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Cirrhosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Tuberculous peritonitis: Tuberculous peritonitis typically presents with a low SAAG, suggesting that the ascites is not due to portal hypertension but to peritoneal inflammation.</li><li>\u2022 Option A. Tuberculous peritonitis:</li><li>\u2022 Option C. Pancreatic ascites: Pancreatic ascites is usually due to leakage of pancreatic enzymes causing inflammation and ascites with a low SAAG, indicating that the cause is not related to portal hypertension.</li><li>\u2022 Option C. Pancreatic ascites:</li><li>\u2022 Option D. Nephrotic syndrome: Nephrotic syndrome can cause ascites due to hypoalbuminemia leading to reduced oncotic pressure, but it typically results in a low SAAG, as the ascites is not due to portal hypertension.</li><li>\u2022 Option D. Nephrotic syndrome:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A high serum-ascites albumin gradient (SAAG) of 1.1 g/dL or greater is indicative of portal hypertension, with cirrhosis being a common cause, especially in patients with a history of alcohol use disorder.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6062c48",
      "audio": ""
    },
    {
      "text": "A 45-year-old female with no significant medical history presents with abdominal swelling and discomfort. A diagnostic paracentesis shows a SAAG of 0.9 g/dL. Which of the following conditions is most likely associated with her ascites?",
      "options": [
        {
          "label": "A",
          "text": "Budd-Chiari syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Congestive heart failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Malignant ascites",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hepatic venous outflow obstruction",
          "correct": false
        }
      ],
      "correct_answer": "C. Malignant ascites",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Options A. Budd-Chiari syndrome and D. Hepatic venous outflow obstruction : Both typically lead to portal hypertension and would more likely present with a SAAG greater than 1.1 g/dL.</li><li>\u2022 Options A. Budd-Chiari syndrome and D. Hepatic venous outflow obstruction</li><li>\u2022 Option B. Congestive heart failure: Can cause ascites due to increased hydrostatic pressure in the systemic and portal venous systems, typically resulting in a SAAG greater than 1.1 g/dL, indicating that the ascites is due to portal hypertension secondary to heart failure.</li><li>\u2022 Option B. Congestive heart failure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A SAAG lower than 1.1 g/dL suggests the ascites is not due to portal hypertension and that malignant ascites is caused by the direct spread of cancer in the peritoneal cavity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22dfc38a",
      "audio": ""
    },
    {
      "text": "A 50-year-old male with a history of chronic heart failure presents with progressive abdominal distension. Paracentesis reveals a SAAG of 1.3 g/dL. Which of the following is the most likely cause of his ascites?",
      "options": [
        {
          "label": "A",
          "text": "Peritoneal carcinomatosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alcoholic cirrhosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Congestive heart failure",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pancreatic ascites",
          "correct": false
        }
      ],
      "correct_answer": "C. Congestive heart failure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Peritoneal carcinomatosis: Peritoneal carcinomatosis typically leads to exudative ascites with a low SAAG, as the ascites formation is due to peritoneal involvement by malignant cells rather than portal hypertension.</li><li>\u2022 Option A. Peritoneal carcinomatosis:</li><li>\u2022 Option B. Alcoholic cirrhosis: Alcoholic cirrhosis could also present with a high SAAG due to portal hypertension; however, the patient's history of chronic heart failure makes congestive heart failure a more likely cause in this case.</li><li>\u2022 Option B. Alcoholic cirrhosis:</li><li>\u2022 Option D. Pancreatic ascites: Pancreatic ascites usually results from the leakage of pancreatic enzymes, leading to inflammation and exudative ascites with a low SAAG, not related to portal hypertension.</li><li>\u2022 Option D. Pancreatic ascites:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A high SAAG (\u22651.1 g/dL) in a patient with chronic heart failure is indicative of ascites due to congestive heart failure, reflecting portal hypertension secondary to increased venous pressure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "888f237a",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of cirrhosis due to chronic hepatitis C infection presents with new-onset ascites. What is the most appropriate initial step in the management of his ascites?",
      "options": [
        {
          "label": "A",
          "text": "Increase the dose of his current diuretic",
          "correct": false
        },
        {
          "label": "B",
          "text": "Start antibiotic prophylaxis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Perform a large-volume paracentesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Restrict dietary sodium",
          "correct": true
        }
      ],
      "correct_answer": "D. Restrict dietary sodium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Restrict dietary sodium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Increase the dose of his current diuretic: Increasing the dose of his current diuretic without first attempting dietary modifications may lead to electrolyte imbalances and kidney injury.</li><li>\u2022 Option A. Increase the dose of his current diuretic:</li><li>\u2022 Option B. Start antibiotic prophylaxis: Antibiotic prophylaxis is indicated in specific situations, such as prior episodes of spontaneous bacterial peritonitis (SBP), but not as an initial step for all cases of ascites.</li><li>\u2022 Option B. Start antibiotic prophylaxis:</li><li>\u2022 Option C. Perform a large-volume paracentesis: Large-volume paracentesis is typically reserved for tense ascites causing respiratory discomfort or as a diagnostic procedure.</li><li>\u2022 Option C. Perform a large-volume paracentesis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dietary sodium restriction is the initial management strategy for patients with cirrhosis presenting with ascites.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "697b4074",
      "audio": ""
    },
    {
      "text": "A 55-year-old woman with cirrhosis is evaluated in the clinic. She is oriented to person, place, and time but demonstrates poor concentration and mild confusion about recent events. She has no asterixis or other focal neurological signs. According to the West Haven Criteria, how would her hepatic encephalopathy be graded?",
      "options": [
        {
          "label": "A",
          "text": "Grade I",
          "correct": true
        },
        {
          "label": "B",
          "text": "Grade II",
          "correct": false
        },
        {
          "label": "C",
          "text": "Grade III",
          "correct": false
        },
        {
          "label": "D",
          "text": "Grade IV",
          "correct": false
        }
      ],
      "correct_answer": "A. Grade I",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Grade I</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Grade II: Hepatic encephalopathy is characterized by increased confusion, disorientation to time, obvious personality changes, inappropriate behavior, and asterixis (flapping tremor).</li><li>\u2022 Option B. Grade II:</li><li>\u2022 Option C. Grade III: Involves a somnolent but arousable state, profound confusion, disorientation to time and place, and more pronounced asterixis.</li><li>\u2022 Option C. Grade III:</li><li>\u2022 Option D. Grade IV: Is characterized by coma with or without response to painful stimuli.</li><li>\u2022 Option D. Grade IV:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Grade I is characterized by mild confusion and poor concentration without more severe neurological signs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9daa5ad8",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate long-term treatment to prevent further episodes of hepatic encephalopathy in a patient with advanced cirrhosis?",
      "options": [
        {
          "label": "A",
          "text": "Oral lactulose",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intravenous albumin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral propranolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "High-dose vitamin K",
          "correct": false
        }
      ],
      "correct_answer": "A. Oral lactulose",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Oral lactulose</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Intravenous albumin: Intravenous albumin is used in the management of patients with cirrhosis and complications such as spontaneous bacterial peritonitis or hepatorenal syndrome, but it is not a standard treatment for preventing hepatic encephalopathy.</li><li>\u2022 Option B. Intravenous albumin:</li><li>\u2022 Option C. Oral propranolol: Oral propranolol is used for primary prophylaxis of variceal bleeding in cirrhotic patients by reducing portal hypertension, not for preventing hepatic encephalopathy.</li><li>\u2022 Option C. Oral propranolol:</li><li>\u2022 Option D. High-dose vitamin K: High-dose vitamin K is sometimes used in cirrhotic patients to correct coagulopathy, but it does not play a role in the prevention of hepatic encephalopathy.</li><li>\u2022 Option D. High-dose vitamin K:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Oral lactulose is the most appropriate long-term treatment for preventing recurrent episodes of hepatic encephalopathy in patients with advanced cirrhosis, due to its mechanism of reducing blood ammonia levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d71bae88",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a history of alcohol abuse and chronic hepatitis B infection is found to have an elevated alpha-fetoprotein (AFP) level during routine screening making him vulnerable for ?",
      "options": [
        {
          "label": "A",
          "text": "Renal cell carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatocellular carcinoma (HCC)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pancreatic adenocarcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Colorectal adenocarcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Hepatocellular carcinoma (HCC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Renal cell carcinoma: Renal cell carcinoma is not typically associated with alcohol abuse, hepatitis B infection, or elevated AFP levels.</li><li>\u2022 Option A. Renal cell carcinoma:</li><li>\u2022 Option C. Pancreatic adenocarcinoma: Pancreatic adenocarcinoma is also not directly linked to alcohol abuse, hepatitis B infection, or elevated AFP levels as specific risk factors or biomarkers.</li><li>\u2022 Option C. Pancreatic adenocarcinoma:</li><li>\u2022 Option D. Colorectal adenocarcinoma: Colorectal adenocarcinoma, while alcohol consumption may be a risk factor, is not directly associated with hepatitis B infection or elevated AFP levels as a specific biomarker.</li><li>\u2022 Option D. Colorectal adenocarcinoma:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alcohol abuse and chronic hepatitis B infection, combined with an elevated alpha-fetoprotein (AFP) level, significantly increases the likelihood of developing hepatocellular carcinoma (HCC).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "19dcb463",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman with a history of non-alcoholic steatohepatitis (NASH) presents with worsening fatigue and abdominal distension. An abdominal ultrasound reveals a nodular liver and ascites. Which additional finding would most suggest the presence of hepatocellular carcinoma (HCC)?",
      "options": [
        {
          "label": "A",
          "text": "Hypoglycemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated alpha-fetoprotein (AFP)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hyponatremia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypoalbuminemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Elevated alpha-fetoprotein (AFP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Elevated alpha-fetoprotein (AFP)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypoglycemia: Hypoglycemia can occur in advanced liver disease due to the liver's impaired gluconeogenesis, but it is not specific for HCC.</li><li>\u2022 Option A. Hypoglycemia:</li><li>\u2022 Option C. Hyponatremia: Hyponatremia is common in advanced liver disease, particularly with the development of ascites and portal hypertension, but it is not specific for HCC.</li><li>\u2022 Option C. Hyponatremia:</li><li>\u2022 Option D. Hypoalbuminemia: Hypoalbuminemia is indicative of liver dysfunction and is a common feature of cirrhosis and advanced liver disease but does not specifically suggest HCC.</li><li>\u2022 Option D. Hypoalbuminemia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An elevated alpha-fetoprotein (AFP) level, particularly in a patient with risk factors and liver disease such as NASH, is suggestive of hepatocellular carcinoma (HCC).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "190b8e39",
      "audio": ""
    },
    {
      "text": "Which imaging characteristic on contrast-enhanced computed tomography (CECT) is most indicative of hepatocellular carcinoma (HCC)?",
      "options": [
        {
          "label": "A",
          "text": "Early arterial enhancement with washout in the venous phase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Continuous enhancement in both arterial and venous phases",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lack of enhancement in all phases",
          "correct": false
        },
        {
          "label": "D",
          "text": "Late venous enhancement without arterial enhancement",
          "correct": false
        }
      ],
      "correct_answer": "A. Early arterial enhancement with washout in the venous phase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Early arterial enhancement with washout in the venous phase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Continuous enhancement in both arterial and venous phases: It  is not typical for HCC and may suggest other types of lesions or benign vascular processes.</li><li>\u2022 Option B. Continuous enhancement in both arterial and venous phases:</li><li>\u2022 Option C. Lack of enhancement in all phases: It is not characteristic of HCC. HCC typically shows some degree of contrast enhancement due to its arterial supply.</li><li>\u2022 Option C. Lack of enhancement in all phases:</li><li>\u2022 Option D. Late venous enhancement without arterial enhancement: It is not a typical feature of HCC and may be seen in other types of liver lesions or vascular abnormalities.</li><li>\u2022 Option D. Late venous enhancement without arterial enhancement:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Early arterial enhancement with washout in the venous phase on contrast-enhanced computed tomography (CECT) is a key imaging characteristic indicative of hepatocellular carcinoma (HCC) in patients with liver disease, such as cirrhosis due to chronic hepatitis C.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "00ac5f0e",
      "audio": ""
    },
    {
      "text": "What is the most appropriate first-line treatment option for early-stage hepatocellular carcinoma (HCC) and well-preserved liver function?",
      "options": [
        {
          "label": "A",
          "text": "Systemic chemotherapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liver transplantation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Radiofrequency ablation (RFA)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Palliative care",
          "correct": false
        }
      ],
      "correct_answer": "C. Radiofrequency ablation (RFA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Radiofrequency ablation (RFA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Systemic chemotherapy: Systemic chemotherapy is generally not the first-line treatment for early-stage HCC due to its limited efficacy and potential for systemic side effects.</li><li>\u2022 Option A. Systemic chemotherapy:</li><li>\u2022 Option B. Liver transplantation: Liver transplantation is a potential treatment option for early-stage HCC, especially for patients with underlying cirrhosis and liver dysfunction. However, it is typically considered when other curative treatments like resection or ablation are not feasible or have failed, and the patient meets specific criteria (such as the Milan criteria).</li><li>\u2022 Option B. Liver transplantation:</li><li>\u2022 Option D. Palliative care: Palliative care is an important aspect of managing advanced cancer but is not the appropriate first-line treatment for a patient with early-stage HCC and well-preserved liver function, who has potentially curative treatment options.</li><li>\u2022 Option D. Palliative care:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Radiofrequency ablation (RFA) is an appropriate first-line treatment for patients with early-stage hepatocellular carcinoma (HCC) and well-preserved liver function, offering a minimally invasive approach with the potential for curative outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0d92a28",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with acute viral hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated AST, normal ALT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated alkaline phosphatase, normal ALT and AST",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in acute viral hepatitis where both enzymes are usually elevated.</li><li>\u2022 Option A.</li><li>\u2022 Elevated ALT, normal AST</li><li>\u2022 Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with acute viral hepatitis.</li><li>\u2022 Option B. Elevated AST, normal ALT</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than acute viral hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In acute viral hepatitis, both ALT and AST levels are typically elevated, reflecting hepatocellular injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dfcc1172",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with ischemic hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated AST, normal ALT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated alkaline phosphatase, normal ALT and AST",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in ischemic hepatitis, where both enzymes are usually elevated.</li><li>\u2022 Option A. Elevated ALT, normal AST</li><li>\u2022 Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with ischemic hepatitis.</li><li>\u2022 Option B. Elevated AST, normal ALT</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than ischemic hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ischemic hepatitis typically presents with marked elevations in both ALT and AST levels, reflecting acute hepatocellular injury due to compromised hepatic perfusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f60a673",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with acute fulminant Wilson's disease?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated AST, normal ALT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated alkaline phosphatase, normal ALT and AST",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in acute fulminant Wilson's disease, where both enzymes are usually elevated.</li><li>\u2022 Option A. Elevated ALT, normal AST</li><li>\u2022 Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with acute fulminant Wilson's disease.</li><li>\u2022 Option B. Elevated AST, normal ALT</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than acute fulminant Wilson's disease, as alkaline phosphatase levels are typically elevated in cholestasis.</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Acute fulminant Wilson's disease presents with markedly elevated ALT and AST levels, reflecting severe hepatocellular injury and necrosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f06c467e",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with alcoholic hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated AST, normal ALT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated alkaline phosphatase, normal ALT and AST",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in alcoholic hepatitis, where both enzymes are usually elevated.</li><li>\u2022 Option A. Elevated ALT, normal AST</li><li>\u2022 Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with alcoholic hepatitis.</li><li>\u2022 Option B. Elevated AST, normal ALT</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than alcoholic hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.</li><li>\u2022 Option D. Elevated alkaline phosphatase, normal ALT and AST</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Alcoholic hepatitis typically presents with marked elevations in both ALT and AST levels, reflecting hepatocellular injury.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0cac6e0",
      "audio": ""
    },
    {
      "text": "Which of the following calculations is most appropriate to assess the severity and prognosis of alcoholic hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Child-Pugh score",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glasgow Alcoholic Hepatitis Score",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maddrey's Discriminant Function",
          "correct": true
        },
        {
          "label": "D",
          "text": "MELD score",
          "correct": false
        }
      ],
      "correct_answer": "C. Maddrey's Discriminant Function",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Child-Pugh score : While used to assess the severity of liver disease, the Child-Pugh score may not be as specific for alcoholic hepatitis severity as Maddrey's Discriminant Function.</li><li>\u2022 Option A. Child-Pugh score</li><li>\u2022 Option B. Glasgow Alcoholic Hepatitis Score : This scoring system assesses the severity of alcoholic hepatitis but does not specifically incorporate INR, which is a component of Maddrey's Discriminant Function.</li><li>\u2022 Option B. Glasgow Alcoholic Hepatitis Score</li><li>\u2022 Option D. MELD score : The Model for End-Stage Liver Disease (MELD) score is used for liver transplant allocation and does not specifically assess the severity of alcoholic hepatitis.</li><li>\u2022 Option D. MELD score</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Maddrey's Discriminant Function is a valuable tool for assessing the severity and prognosis of alcoholic hepatitis, guiding treatment decisions and predicting mortality in patients with this condition.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "634ffbbe",
      "audio": ""
    },
    {
      "text": "Which of the following is the primary pharmacological treatment for severe alcoholic hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Prednisolone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Pentoxifylline",
          "correct": false
        },
        {
          "label": "C",
          "text": "N-acetylcysteine (NAC)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ursodeoxycholic acid (UDCA)",
          "correct": false
        }
      ],
      "correct_answer": "A. Prednisolone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Pentoxifylline : While also used in the management of severe alcoholic hepatitis, pentoxifylline has shown less efficacy compared to prednisolone in improving short-term survival.</li><li>\u2022 Option B. Pentoxifylline</li><li>\u2022 Option C. N-acetylcysteine (NAC) : NAC is primarily used for acetaminophen overdose and does not have a significant role in the treatment of alcoholic hepatitis.</li><li>\u2022 Option C. N-acetylcysteine (NAC)</li><li>\u2022 Option D. Ursodeoxycholic acid (UDCA) : UDCA is not recommended for the treatment of alcoholic hepatitis as it may worsen outcomes in this condition.</li><li>\u2022 Option D. Ursodeoxycholic acid (UDCA)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Prednisolone is the primary pharmacological treatment for severe alcoholic hepatitis, improving short-term survival by reducing inflammation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ea1145dc",
      "audio": ""
    },
    {
      "text": "A 55-year-old obese patient presents with fatigue, right upper quadrant abdominal pain, and hepatomegaly. Laboratory tests reveal elevated liver enzymes and imaging studies show hepatic steatosis. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Alcoholic liver disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute viral hepatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Autoimmune hepatitis",
          "correct": false
        }
      ],
      "correct_answer": "A. Non-alcoholic fatty liver disease (NAFLD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Alcoholic liver disease : While alcohol consumption can also lead to fatty liver disease, the absence of significant alcohol intake in this patient makes NAFLD more likely.</li><li>\u2022 Option B. Alcoholic liver disease</li><li>\u2022 Option C. Acute viral hepatitis : The clinical presentation and imaging findings are not consistent with acute viral hepatitis, which typically presents with acute onset jaundice and viral prodrome.</li><li>\u2022 Option C. Acute viral hepatitis</li><li>\u2022 Option D. Autoimmune hepatitis : Although autoimmune hepatitis can present with elevated liver enzymes and hepatomegaly, the association with obesity and hepatic steatosis makes NAFLD more likely in this case.</li><li>\u2022 Option D. Autoimmune hepatitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and risk factors for NAFLD, including obesity and hepatic steatosis, aids in the diagnosis and management of non-alcoholic fatty liver disease, which encompasses non-alcoholic steatohepatitis (NASH) as a progressive form.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a43621d8",
      "audio": ""
    },
    {
      "text": "Which of the following histological findings is characteristic of non-alcoholic steatohepatitis (NASH)?",
      "options": [
        {
          "label": "A",
          "text": "Presence of Mallory-Denk bodies",
          "correct": true
        },
        {
          "label": "B",
          "text": "Periportal inflammation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bile duct proliferation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hepatic iron deposition",
          "correct": false
        }
      ],
      "correct_answer": "A. Presence of Mallory-Denk bodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Periportal inflammation : While inflammation is a feature of NASH, it typically involves the lobular region rather than periportal areas.</li><li>\u2022 Option B. Periportal inflammation</li><li>\u2022 Option C. Bile duct proliferation : Bile duct proliferation is not a typical histological finding in NASH and is more suggestive of chronic cholestatic liver diseases.</li><li>\u2022 Option C. Bile duct proliferation</li><li>\u2022 Option D. Hepatic iron deposition : Hepatic iron deposition is not a characteristic histological finding in NASH and is more commonly associated with hereditary hemochromatosis or chronic liver disease.</li><li>\u2022 Option D. Hepatic iron deposition</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Characteristic histological features of NASH, such as Mallory-Denk bodies, helps in the accurate diagnosis and differentiation from other liver diseases, guiding appropriate management strategies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a16ef8d2",
      "audio": ""
    },
    {
      "text": "Which of the following is the primary pharmacological treatment for NASH?",
      "options": [
        {
          "label": "A",
          "text": "Ursodeoxycholic acid (UDCA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pioglitazone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vitamin E",
          "correct": false
        }
      ],
      "correct_answer": "B. Pioglitazone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ursodeoxycholic acid (UDCA) : UDCA has not shown consistent efficacy in treating NASH and is not recommended as a primary pharmacological treatment.</li><li>\u2022 Option A. Ursodeoxycholic acid (UDCA)</li><li>\u2022 Option C. Metformin : While metformin may improve insulin sensitivity, its role in treating NASH is limited and controversial.</li><li>\u2022 Option C. Metformin</li><li>\u2022 Option D. Vitamin E : Vitamin E has shown some benefit in improving liver histology in NASH patients without diabetes but is not considered a first-line treatment option.</li><li>\u2022 Option D. Vitamin E</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 NASH, such as pioglitazone, aids in the management of this progressive liver disease, particularly in patients with associated metabolic risk factors like diabetes or insulin resistance.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f7e8a49",
      "audio": ""
    },
    {
      "text": "Which of the following patterns of liver function tests (LFTs) is most consistent with cholestatic liver disease?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ALT and AST",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated ALT, normal AST",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated ALP and GGT, normal ALT and AST",
          "correct": true
        },
        {
          "label": "D",
          "text": "Elevated bilirubin, normal ALP and GGT",
          "correct": false
        }
      ],
      "correct_answer": "C. Elevated ALP and GGT, normal ALT and AST",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Elevated ALT and AST : This pattern is more indicative of hepatocellular injury rather than cholestasis.</li><li>\u2022 Option A. Elevated ALT and AST</li><li>\u2022 Option B. Elevated ALT, normal AST : Elevated ALT with normal AST levels is not characteristic of cholestatic liver diseases.</li><li>\u2022 Option B. Elevated ALT, normal AST</li><li>\u2022 Option D. Elevated bilirubin, normal ALP and GGT : While elevated bilirubin can occur in cholestatic liver diseases, normal ALP and GGT levels are inconsistent with impaired bile flow.</li><li>\u2022 Option D. Elevated bilirubin, normal ALP and GGT</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The characteristic pattern of elevated ALP and GGT levels with normal ALT and AST helps in distinguishing cholestatic liver diseases from other causes of liver dysfunction, guiding further diagnostic evaluation and management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f9ce3e5",
      "audio": ""
    },
    {
      "text": "A 20-year-old male presents with intermittent episodes of mild jaundice, particularly during periods of stress or fasting. Laboratory tests reveal unconjugated hyperbilirubinemia with normal liver function tests. Which of the following conditions is most likely responsible for the patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Wilson's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gilbert Syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dubin-Johnson syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Gilbert Syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Wilson's disease : Wilson's disease presents with hepatic copper accumulation leading to liver dysfunction, neurological symptoms, and Kayser-Fleischer rings, which are not present in Gilbert Syndrome.</li><li>\u2022 Option A. Wilson's disease</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is associated with abnormal liver function tests reflecting increased bilirubin turnover.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option D. Dubin-Johnson syndrome : Dubin-Johnson syndrome is characterized by conjugated hyperbilirubinemia due to impaired bilirubin excretion into bile, resulting in darkly pigmented liver tissue, which is not seen in Gilbert Syndrome.</li><li>\u2022 Option D. Dubin-Johnson syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The clinical presentation and laboratory findings of Gilbert Syndrome, includes unconjugated hyperbilirubinemia with normal liver function tests.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc089227",
      "audio": ""
    },
    {
      "text": "A 2-week-old neonate presents with severe jaundice since birth. Laboratory tests reveal markedly elevated unconjugated bilirubin levels without evidence of hemolysis or liver dysfunction. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Gilbert Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar Syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dubin-Johnson Syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Crigler-Najjar Syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Gilbert Syndrome : Gilbert Syndrome also presents with unconjugated hyperbilirubinemia but is milder and typically presents later in life.</li><li>\u2022 Option A. Gilbert Syndrome</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia, but it is associated with evidence of hemolysis on laboratory tests, which is not present in Crigler-Najjar Syndrome.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option D. Dubin-Johnson Syndrome : Dubin-Johnson Syndrome presents with conjugated hyperbilirubinemia and is characterized by darkly pigmented liver tissue, which is not seen in Crigler-Najjar Syndrome.</li><li>\u2022 Option D. Dubin-Johnson Syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The clinical presentation and laboratory findings of Crigler-Najjar Syndrome, includes severe unconjugated hyperbilirubinemia without evidence of hemolysis or liver dysfunction, is essential for early diagnosis and appropriate management, which may include phototherapy or liver transplantation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "efecfd2d",
      "audio": ""
    },
    {
      "text": "A 30-year-old female presents with chronic jaundice and dark-colored urine. Laboratory tests reveal elevated levels of conjugated bilirubin and normal liver function tests. Abdominal imaging shows a liver with a characteristic \"black liver\" appearance. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Gilbert Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dubin-Johnson Syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Dubin-Johnson Syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-115621.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Gilbert Syndrome : Gilbert Syndrome presents with unconjugated hyperbilirubinemia due to reduced activity of UDP-glucuronosyltransferase (UGT1A1), without evidence of liver dysfunction or bile pigment deposition.</li><li>\u2022 Option A. Gilbert Syndrome</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is not associated with conjugated hyperbilirubinemia or liver pigment deposition.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option C. Crigler-Najjar Syndrome : Crigler-Najjar Syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), without evidence of liver pigment deposition.</li><li>\u2022 Option C. Crigler-Najjar Syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and characteristic imaging findings of Dubin-Johnson Syndrome, including conjugated hyperbilirubinemia and a \"black liver\" appearance, aids in accurate diagnosis and differentiation from other causes of jaundice.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "67a1d35e",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with chronic jaundice and dark urine with elevated levels of conjugated bilirubin with normal liver function tests. Abdominal imaging shows no abnormalities. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Gilbert Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rotor Syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Rotor Syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Gilbert Syndrome : Gilbert Syndrome presents with unconjugated hyperbilirubinemia due to reduced activity of UDP-glucuronosyltransferase (UGT1A1), with normal liver function tests and no evidence of conjugated hyperbilirubinemia.</li><li>\u2022 Option A. Gilbert Syndrome</li><li>\u2022 Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is not associated with conjugated hyperbilirubinemia.</li><li>\u2022 Option B. Hemolytic anemia</li><li>\u2022 Option C. Crigler-Najjar Syndrome : Crigler-Najjar Syndrome is characterized by severe unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), with normal liver function tests and no evidence of conjugated hyperbilirubinemia.</li><li>\u2022 Option C. Crigler-Najjar Syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of Rotor Syndrome, includes conjugated hyperbilirubinemia with normal liver function tests and absence of liver imaging abnormalities.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1fff896",
      "audio": ""
    },
    {
      "text": "A 6-month-old infant presents with persistent jaundice, hepatosplenomegaly, and failure to thrive. Laboratory tests reveal elevated levels of conjugated bilirubin and liver function tests consistent with cholestasis. Abdominal imaging shows no abnormalities. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Wilson's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alagille syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Progressive familial intrahepatic cholestasis (PFIC)",
          "correct": true
        }
      ],
      "correct_answer": "D. Progressive familial intrahepatic cholestasis (PFIC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Wilson's disease : Wilson's disease presents with hepatic copper accumulation leading to liver dysfunction and neurological symptoms, which are not typical features of PFIC.</li><li>\u2022 Option A. Wilson's disease</li><li>\u2022 Option B. Alagille syndrome : Alagille syndrome presents with bile duct paucity, characteristic facial features, and cardiac abnormalities, which are not features of PFIC.</li><li>\u2022 Option B. Alagille syndrome</li><li>\u2022 Option C. Crigler-Najjar syndrome : Crigler-Najjar syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), which is different from the cholestatic presentation seen in PFIC.</li><li>\u2022 Option C. Crigler-Najjar syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of progressive familial intrahepatic cholestasis (PFIC), includes cholestasis with elevated conjugated bilirubin levels and normal or mildly abnormal liver function tests.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e363f314",
      "audio": ""
    },
    {
      "text": "A 4-year-old child presents with jaundice, pruritus, cardiac murmur and characteristic facial features as below. Laboratory tests show elevated levels of conjugated bilirubin and liver function tests consistent with cholestasis. Which of the following conditions is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Wilson's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Progressive familial intrahepatic cholestasis (PFIC)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Crigler-Najjar syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alagille syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Alagille syndrome",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-130600.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-130600_Lr5LzCE.jpg"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Wilson's disease : Wilson's disease presents with hepatic copper accumulation leading to liver dysfunction and neurological symptoms, which are not typical features of Alagille syndrome.</li><li>\u2022 Option A. Wilson's disease</li><li>\u2022 Option B. Progressive familial intrahepatic cholestasis (PFIC) : PFIC is characterized by defects in hepatobiliary transport proteins, leading to cholestasis, but it does not typically present with the characteristic facial features seen in Alagille syndrome.</li><li>\u2022 Option B. Progressive familial intrahepatic cholestasis (PFIC)</li><li>\u2022 Option C. Crigler-Najjar syndrome : Crigler-Najjar syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), which is different from the cholestatic presentation seen in Alagille syndrome.</li><li>\u2022 Option C. Crigler-Najjar syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The clinical presentation and characteristic facial features of Alagille syndrome, along with laboratory findings consistent with cholestasis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0267f9a7",
      "audio": ""
    },
    {
      "text": "Which of the following manifestations is a rare but severe complication most likely associated with acute hepatitis B infection?",
      "options": [
        {
          "label": "A",
          "text": "Chronic liver cirrhosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatocellular carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fulminant hepatic failure",
          "correct": true
        },
        {
          "label": "D",
          "text": "Chronic hepatitis B infection",
          "correct": false
        }
      ],
      "correct_answer": "C. Fulminant hepatic failure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic liver cirrhosis : Chronic liver cirrhosis is a long-term complication of chronic hepatitis B infection, not typically seen in the acute phase.</li><li>\u2022 Option A. Chronic liver cirrhosis</li><li>\u2022 Option B. Hepatocellular carcinoma : Hepatocellular carcinoma is a long-term complication of chronic hepatitis B infection and is not associated with the acute phase of the disease.</li><li>\u2022 Option B. Hepatocellular carcinoma</li><li>\u2022 Option D. Chronic hepatitis B infection : Chronic hepatitis B infection is characterized by persistent HBsAg positivity for more than six months and is not typically associated with acute manifestations.</li><li>\u2022 Option D. Chronic hepatitis B infection</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The manifestations of acute hepatitis B infection, includes fulminant hepatic failure which is a severe complication, aids in prompt diagnosis and management, preventing progression to life-threatening complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6533f754",
      "audio": ""
    },
    {
      "text": "A 28-year-old female presents for routine health screening. Laboratory tests reveal positive serology for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), with elevated liver enzymes. Which of the following best describes the patient's hepatitis B virus (HBV) infection status?",
      "options": [
        {
          "label": "A",
          "text": "Immune tolerance phase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immune clearance phase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Immune escape phase",
          "correct": false
        }
      ],
      "correct_answer": "B. Immune clearance phase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Immune tolerance phase : In the immune tolerance phase, patients have high viral loads, normal liver enzymes, and positive HBeAg. There is minimal liver inflammation despite active viral replication.</li><li>\u2022 Option A. Immune tolerance phase</li><li>\u2022 Option C. Immune control phase : In the immune control phase, patients have low viral loads, normal liver enzymes, and negative HBeAg. There is minimal liver inflammation due to effective immune control of the virus.</li><li>\u2022 Option C. Immune control phase</li><li>\u2022 Option D. Immune escape phase : The immune escape phase refers to the development of HBV mutants that evade immune recognition, typically occurring in chronic infection and associated with disease progression.</li><li>\u2022 Option D. Immune escape phase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The different phases of hepatitis B virus (HBV) infection, includes the immune clearance phase characterized by active viral replication and elevated liver enzymes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93664eb0",
      "audio": ""
    },
    {
      "text": "Which of the following best describes a patient's hepatitis B virus (HBV) infection status if he has positive serology for hepatitis B surface antigen (HBsAg) , who has come for a routine check up ?",
      "options": [
        {
          "label": "A",
          "text": "Chronic hepatitis B infection",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute hepatitis B infection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Resolved hepatitis B infection",
          "correct": false
        }
      ],
      "correct_answer": "A. Chronic hepatitis B infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Acute hepatitis B infection : Acute infection is characterized by the presence of HBsAg along with other markers such as IgM anti-HBc and HBV DNA.</li><li>\u2022 Option B. Acute hepatitis B infection</li><li>\u2022 Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative HBeAg.</li><li>\u2022 Option C. Immune control phase</li><li>\u2022 Option D. Resolved hepatitis B infection : Resolved infection is characterized by the presence of anti-HBs and absence of HBsAg.</li><li>\u2022 Option D. Resolved hepatitis B infection</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HBsAg positivity indicates chronic hepatitis B infection that helps in appropriate management and monitoring of patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2244d0fe",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the patient's hepatitis B virus (HBV) infection status if she has positive serology for anti-HBs?",
      "options": [
        {
          "label": "A",
          "text": "Chronic hepatitis B infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute hepatitis B infection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Resolved hepatitis B infection",
          "correct": true
        }
      ],
      "correct_answer": "D. Resolved hepatitis B infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic hepatitis B infection : Chronic infection is characterized by persistent HBsAg positivity.</li><li>\u2022 Option A. Chronic hepatitis B infection</li><li>\u2022 Option B. Acute hepatitis B infection : Acute infection is characterized by the presence of HBsAg, often accompanied by IgM anti-HBc.</li><li>\u2022 Option B. Acute hepatitis B infection</li><li>\u2022 Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative HBeAg.</li><li>\u2022 Option C. Immune control phase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Anti-HBs positivity helps in indicating resolved hepatitis B infection or immunity from vaccination.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "97d6f0c4",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the patient's hepatitis B virus (HBV) infection status if patient shows positive serology for hepatitis B e antigen (HBeAg) ?",
      "options": [
        {
          "label": "A",
          "text": "Immune tolerance phase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Immune clearance phase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Immune escape phase",
          "correct": false
        }
      ],
      "correct_answer": "A. Immune tolerance phase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Immune clearance phase : In the immune clearance phase, patients have high viral loads, elevated liver enzymes, and positive HBeAg.</li><li>\u2022 Option B. Immune clearance phase</li><li>\u2022 Option C. Immune control phase : In the immune control phase, patients have low viral loads, normal liver enzymes, and negative HBeAg.</li><li>\u2022 Option C. Immune control phase</li><li>\u2022 Option D. Immune escape phase : The immune escape phase refers to the development of HBV mutants that evade immune recognition, typically occurring in chronic infection and associated with disease progression.</li><li>\u2022 Option D. Immune escape phase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The significance of HBeAg positivity helps in indicating the immune tolerance phase of hepatitis B infection</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c62b0510",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the patient's hepatitis B virus (HBV) infection status if laboratory tests reveal positive serology for IgM antibodies to hepatitis B core antigen (anti-HBc IgM)?",
      "options": [
        {
          "label": "A",
          "text": "Chronic hepatitis B infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute hepatitis B infection",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Resolved hepatitis B infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Acute hepatitis B infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic hepatitis B infection : Chronic infection is characterized by persistent HBsAg positivity and absence of IgM anti-HBc.</li><li>\u2022 Option A. Chronic hepatitis B infection</li><li>\u2022 Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative anti-HBc IgM.</li><li>\u2022 Option C. Immune control phase</li><li>\u2022 Option D. Resolved hepatitis B infection : Resolved infection is characterized by the presence of anti-HBs and absence of HBsAg and IgM anti-HBc.</li><li>\u2022 Option D. Resolved hepatitis B infection</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 IgM anti-HBc positivity indicates acute hepatitis B infection that aids in prompt diagnosis and management of patients presenting with acute hepatitis symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "99cf3540",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the patient's hepatitis B virus (HBV) infection status in a patient with chronic Hepatitis B infection and positive serology for antibodies to hepatitis B e antigen (anti-HBe)?",
      "options": [
        {
          "label": "A",
          "text": "Immune tolerance phase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immune clearance phase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immune control phase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Immune escape phase",
          "correct": false
        }
      ],
      "correct_answer": "C. Immune control phase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Immune tolerance phase : In the immune tolerance phase, patients have high viral loads, normal liver enzymes, and positive HBeAg.</li><li>\u2022 Option A. Immune tolerance phase</li><li>\u2022 Option B. Immune clearance phase : In the immune clearance phase, patients have high viral loads, elevated liver enzymes, and positive HBeAg.</li><li>\u2022 Option B. Immune clearance phase</li><li>\u2022 Option D. Immune escape phase : The immune escape phase refers to the development of HBV mutants that evade immune recognition, typically occurring in chronic infection and associated with disease progression.</li><li>\u2022 Option D. Immune escape phase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Anti-HBe positivity indicates the immune control phase of hepatitis B infection that helps in understanding disease progression and guiding management strategies for patients with chronic hepatitis B.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f616e21",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient with chronic hepatitis B infection presents with elevated liver enzymes and detectable HBV DNA levels. The patient has no evidence of cirrhosis or hepatocellular carcinoma. Which of the following is the most appropriate initial treatment according to current guidelines?",
      "options": [
        {
          "label": "A",
          "text": "Lamivudine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Interferon-alpha",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tenofovir disoproxil fumarate (TDF)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Adefovir dipivoxil",
          "correct": false
        }
      ],
      "correct_answer": "C. Tenofovir disoproxil fumarate (TDF)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Lamivudine : Lamivudine is an older nucleoside analog and is associated with high rates of resistance, making it a less preferred option for initial treatment.</li><li>\u2022 Option A. Lamivudine</li><li>\u2022 Option B. Interferon-alpha : Interferon-alpha is less commonly used due to its side effect profile and limited efficacy compared to nucleos(t)ide analogs.</li><li>\u2022 Option B. Interferon-alpha</li><li>\u2022 Option D. Adefovir dipivoxil : Adefovir dipivoxil is another nucleotide analog, but it is associated with a higher rate of nephrotoxicity and resistance compared to TDF or entecavir.</li><li>\u2022 Option D. Adefovir dipivoxil</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The current treatment guidelines for chronic hepatitis B infection, includes the preference for nucleos(t)ide analogs such as tenofovir disoproxil fumarate (TDF) or entecavir as initial therapy that aids in appropriate management and prevention of disease progression.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "97ffc3c8",
      "audio": ""
    },
    {
      "text": "What is the most appropriate interval for monitoring liver function tests and viral load during tenofovir disoproxil fumarate (TDF) therapy for chronic hepatitis B infection?",
      "options": [
        {
          "label": "A",
          "text": "Every 6 months",
          "correct": false
        },
        {
          "label": "B",
          "text": "Every 12 months",
          "correct": false
        },
        {
          "label": "C",
          "text": "Every 3 months",
          "correct": true
        },
        {
          "label": "D",
          "text": "Every 2 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. Every 3 months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Every 6 months : Monitoring every 6 months may not be frequent enough to detect changes in viral load or liver function tests in patients receiving antiviral therapy for chronic hepatitis B infection.</li><li>\u2022 Option A. Every 6 months</li><li>\u2022 Option B. Every 12 months : Monitoring every 12 months is too infrequent for patients on antiviral therapy, as changes in viral load or liver function may occur earlier and require intervention.</li><li>\u2022 Option B. Every 12 months</li><li>\u2022 Option D. Every 2 weeks : Monitoring every 2 weeks is too frequent and may not be necessary for stable patients on antiviral therapy for chronic hepatitis B infection.</li><li>\u2022 Option D. Every 2 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The appropriate monitoring intervals for patients on antiviral therapy for chronic hepatitis B infection, includes regular assessments of liver function tests and viral load every 3 months and ensuring effective management and timely adjustment of treatment as needed.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "06a50aa5",
      "audio": ""
    },
    {
      "text": "Which of the following are confirmatory tests for active HCV infection?",
      "options": [
        {
          "label": "A",
          "text": "HCV RNA PCR",
          "correct": true
        },
        {
          "label": "B",
          "text": "HCV core antigen assay",
          "correct": false
        },
        {
          "label": "C",
          "text": "HCV genotyping",
          "correct": false
        },
        {
          "label": "D",
          "text": "Liver biopsy",
          "correct": false
        }
      ],
      "correct_answer": "A. HCV RNA PCR",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. The HCV core antigen assay can be used as an alternative to HCV RNA PCR in some cases to confirm active infection, but HCV RNA PCR remains the gold standard for confirming active HCV replication.</li><li>\u2022 Option B.</li><li>\u2022 Option C. HCV genotyping is important for determining the genotype of the HCV virus, which can influence treatment decisions. However, it is not the initial confirmatory test for active infection; it is typically done after confirming active infection with HCV RNA PCR.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Liver biopsy is an invasive procedure used to assess liver damage and is not used as a confirmatory test for active HCV infection. It may be used in certain clinical scenarios to assess the extent of liver fibrosis or cirrhosis but is not necessary for the initial diagnosis of HCV.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HCV RNA PCR is the confirmatory test for active infection following positive anti-HCV antibody serology that aids in accurate diagnosis and appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f70482a1",
      "audio": ""
    },
    {
      "text": "A 35-year-old patient with a history of blood transfusion 20 years ago tests positive for anti-HCV antibodies and elevated liver enzymes. Which of the following best describes the patient's HCV infection status?",
      "options": [
        {
          "label": "A",
          "text": "Acute HCV infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic HCV infection",
          "correct": true
        },
        {
          "label": "C",
          "text": "Resolved HCV infection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reinfection with HCV",
          "correct": false
        }
      ],
      "correct_answer": "B. Chronic HCV infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acute HCV infection typically refers to the initial 6 months following exposure to the virus. The history of a blood transfusion 20 years ago and the current presentation suggest a time frame beyond the acute phase.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Resolved HCV infection would be suggested by the presence of anti-HCV antibodies without detectable viral RNA and without elevated liver enzymes, indicating that the patient's immune system cleared the infection.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Reinfection with HCV implies that the patient had previously cleared the virus (either spontaneously or with treatment) and then was exposed to the virus again. This scenario would also require evidence of viral RNA to confirm ongoing infection.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The presence of anti-HCV antibodies along with elevated liver enzymes in a patient with a risk factor for HCV exposure suggests chronic HCV infection, particularly when the exposure occurred more than 6 months prior.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "890401ac",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient presents tests positive for anti-HCV antibodies and elevated liver enzymes. Which of the following statements regarding HCV serology is correct?",
      "options": [
        {
          "label": "A",
          "text": "Anti-HCV antibodies indicate active HCV infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "HCV RNA PCR is not necessary if anti-HCV antibodies are positive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Resolved HCV infection is characterized by positive HCV RNA PCR",
          "correct": false
        },
        {
          "label": "D",
          "text": "HCV core antigen assay is used to detect prior HCV exposure",
          "correct": true
        }
      ],
      "correct_answer": "D. HCV core antigen assay is used to detect prior HCV exposure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti-HCV antibodies indicate exposure to the HCV virus but do not differentiate between active and resolved infections. The presence of antibodies alone cannot confirm active HCV infection.</li><li>\u2022 Option A.</li><li>\u2022 Option B . HCV RNA PCR testing is necessary to confirm active HCV infection even if anti-HCV antibodies are positive. This is because anti-HCV antibodies can be present in both active and resolved infections.</li><li>\u2022 Option B</li><li>\u2022 Option C. Resolved HCV infection is characterized by the presence of anti-HCV antibodies without detectable HCV RNA. The absence of HCV RNA indicates that the virus is not currently replicating in the patient's body.</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 HCV core antigen assay helps to detect prior HCV exposure, that aids in accurate diagnosis and management of hepatitis C virus (HCV) infection.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a4de656",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with history of intravenous drug use tests positive for anti-HCV antibodies and a confirmatory HCV RNA PCR test indicates active infection. Genotyping shows genotype 1a HCV. His liver function tests are mildly elevated. There is no evidence of cirrhosis on imaging. What is the most appropriate next step in managing this patient's HCV infection?",
      "options": [
        {
          "label": "A",
          "text": "Initiate treatment with pegylated interferon and ribavirin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Perform a liver biopsy to assess the degree of liver fibrosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Start direct-acting antiviral (DAA) therapy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Recommend abstinence from alcohol and re-evaluate in 6 months",
          "correct": false
        }
      ],
      "correct_answer": "C. Start direct-acting antiviral (DAA) therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Pegylated interferon and ribavirin were used in the past but are now largely replaced by DAAs due to the latter's superior efficacy and safety profile.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Liver biopsy to assess fibrosis is less commonly performed now due to the availability of non-invasive methods for assessing liver damage and the universal treatment recommendation for HCV regardless of fibrosis stage.</li><li>\u2022 Option B.</li><li>\u2022 Option D. While recommending abstinence from alcohol is important for liver health, it is not a substitute for antiviral treatment in patients with active HCV infection.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The management of chronic HCV infection with direct-acting antivirals is the standard of care. It emphasizes the shift away from older treatments like pegylated interferon and ribavirin to DAAs, which offer better efficacy, safety, and a shorter treatment duration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9c885f8",
      "audio": ""
    },
    {
      "text": "For a 55-year-old female with chronic HCV infection genotype 2, without cirrhosis, what is the most appropriate treatment regimen?",
      "options": [
        {
          "label": "A",
          "text": "Ledipasvir/Sofosbuvir for 12 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sofosbuvir/Velpatasvir for 12 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "Elbasvir/Grazoprevir for 12 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sofosbuvir and ribavirin for 24 weeks",
          "correct": false
        }
      ],
      "correct_answer": "B. Sofosbuvir/Velpatasvir for 12 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ledipasvir/sofosbuvir is highly effective in treating HCV genotype 1 infections but is not the first choice for genotype 2.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Elbasvir/grazoprevir is primarily used for HCV genotype 1 and 4 infections, and thus not the optimal choice for genotype 2.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Sofosbuvir and ribavirin for 24 weeks is an older regimen that may be considered in certain contexts for genotype 2 but is less preferable due to the longer treatment duration and side effects associated with ribavirin.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The efficacy of sofosbuvir/velpatasvir for 12 weeks helps  in treating HCV genotype 2 infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc9886f5",
      "audio": ""
    },
    {
      "text": "A 35-year-old female presents with fatigue, jaundice, and abdominal discomfort for the past few weeks. Laboratory tests reveal elevated liver enzymes, hypergammaglobulinemia, and positive antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA). What is the most likely diagnosis based on these findings?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic hepatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Autoimmune hepatitis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Primary biliary cholangitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Autoimmune hepatitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alcoholic hepatitis : While alcoholic hepatitis can present with similar symptoms, it is typically associated with a history of excessive alcohol consumption and may not have the characteristic autoantibodies seen in autoimmune hepatitis.</li><li>\u2022 Option A. Alcoholic hepatitis</li><li>\u2022 Option B. Non-alcoholic fatty liver disease (NAFLD) : NAFLD typically presents with elevated liver enzymes and fatty infiltration of the liver but lacks the characteristic autoimmune serological markers seen in autoimmune hepatitis.</li><li>\u2022 Option B. Non-alcoholic fatty liver disease (NAFLD)</li><li>\u2022 Option D. Primary biliary cholangitis : Primary biliary cholangitis may present with similar symptoms, but it is characterized by the presence of anti-mitochondrial antibodies (AMA) and histological features of bile duct damage, which are not seen in autoimmune hepatitis.</li><li>\u2022 Option D. Primary biliary cholangitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of autoimmune hepatitis, includes elevated liver enzymes, hypergammaglobulinemia, and positive autoantibodies (ANA and ASMA).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ccd8fda8",
      "audio": ""
    },
    {
      "text": "What is the most appropriate initial treatment for autoimmune hepatitis ?",
      "options": [
        {
          "label": "A",
          "text": "Corticosteroids",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ursodeoxycholic acid (UDCA)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Azathioprine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methotrexate",
          "correct": false
        }
      ],
      "correct_answer": "A. Corticosteroids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Ursodeoxycholic acid (UDCA): UDCA is used in primary biliary cholangitis but is not the first-line treatment for autoimmune hepatitis.</li><li>\u2022 Option B. Ursodeoxycholic acid</li><li>\u2022 Option C. Azathioprine : Azathioprine is often used as a steroid-sparing agent in autoimmune hepatitis but is typically initiated after corticosteroids as maintenance therapy.</li><li>\u2022 Option C. Azathioprine</li><li>\u2022 Option D. Methotrexate : Methotrexate is not a first-line treatment for autoimmune hepatitis and is associated with potential hepatotoxicity.</li><li>\u2022 Option D. Methotrexate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The initial treatment approach for autoimmune hepatitis, is the use of corticosteroids to suppress inflammation and reduce immune-mediated hepatocellular injury, helps in effectively managing the disease and improving patient outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "001ac1eb",
      "audio": ""
    },
    {
      "text": "A 55-year-old female presents with fatigue, pruritus, and right upper quadrant abdominal pain. Laboratory tests show elevated alkaline phosphatase and positive anti-mitochondrial antibodies (AMA). Abdominal imaging reveals hepatomegaly and features suggestive of intrahepatic cholestasis. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic liver disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary biliary cholangitis (PBC)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Autoimmune hepatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": false
        }
      ],
      "correct_answer": "B. Primary biliary cholangitis (PBC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alcoholic liver disease : Alcoholic liver disease typically presents with a history of alcohol abuse and may have elevated liver enzymes but lacks the characteristic AMA positivity seen in PBC.</li><li>\u2022 Option A. Alcoholic liver disease</li><li>\u2022 Option C. Autoimmune hepatitis : Autoimmune hepatitis may present with similar symptoms but is characterized by elevated transaminases and positive antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA), rather than AMA.</li><li>\u2022 Option C. Autoimmune hepatitis</li><li>\u2022 Option D. Non-alcoholic fatty liver disease (NAFLD): NAFLD typically presents with features of metabolic syndrome and may have elevated liver enzymes, but it does not typically present with pruritus or positive AMA.</li><li>\u2022 Option D. Non-alcoholic fatty liver disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation and laboratory findings of primary biliary cholangitis (PBC), includes pruritus, elevated alkaline phosphatase, and positive anti-mitochondrial antibodies (AMA).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6dd99108",
      "audio": ""
    },
    {
      "text": "What is the most appropriate initial pharmacological treatment for early-stage primary biliary cholangitis (PBC)?",
      "options": [
        {
          "label": "A",
          "text": "Ursodeoxycholic acid (UDCA)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Corticosteroids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Azathioprine",
          "correct": false
        }
      ],
      "correct_answer": "A. Ursodeoxycholic acid (UDCA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Corticosteroids : Corticosteroids are not first-line treatment for PBC and may be considered in certain cases of refractory disease or overlap syndromes.</li><li>\u2022 Option B. Corticosteroids</li><li>\u2022 Option C. Methotrexate : Methotrexate is not recommended for the treatment of PBC and is associated with potential hepatotoxicity.</li><li>\u2022 Option C. Methotrexate</li><li>\u2022 Option D. Azathioprine : Azathioprine may be used as an adjunctive therapy in PBC but is not typically initiated as first-line treatment.</li><li>\u2022 Option D. Azathioprine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The initial pharmacological management of primary biliary cholangitis (PBC), includes the use of ursodeoxycholic acid (UDCA) to improve liver function and slow disease progression.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da639808",
      "audio": ""
    },
    {
      "text": "A 45-year-old male presents with fatigue, pruritus, and jaundice. Laboratory tests reveal elevated alkaline phosphatase and serum bilirubin levels. Imaging studies show multifocal strictures and dilatations of the intrahepatic and extrahepatic bile ducts. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic liver disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary sclerosing cholangitis (PSC)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Autoimmune hepatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Non-alcoholic fatty liver disease (NAFLD)",
          "correct": false
        }
      ],
      "correct_answer": "B. Primary sclerosing cholangitis (PSC)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alcoholic liver disease typically presents with a history of significant alcohol consumption and can lead to a spectrum of liver abnormalities, including steatosis, alcoholic hepatitis, and cirrhosis, but it does not typically present with the specific bile duct changes seen in PSC.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Autoimmune hepatitis is characterized by inflammation of the liver due to an autoimmune response and is often associated with elevated transaminases and positive autoimmune markers, which are not the primary findings in this case.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Non-alcoholic fatty liver disease (NAFLD) is associated with metabolic risk factors such as obesity, diabetes, and hyperlipidemia and primarily affects the liver parenchyma, leading to steatosis and potentially steatohepatitis, but it does not cause the bile duct abnormalities seen in PSC.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation of fatigue, pruritus, jaundice, elevated alkaline phosphatase, and serum bilirubin levels, along with characteristic imaging findings of multifocal strictures and dilatations of bile ducts, is typical of primary sclerosing cholangitis (PSC).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9137d57e",
      "audio": ""
    },
    {
      "text": "What histopathological feature is characteristic of primary sclerosing cholangitis (PSC) ?",
      "options": [
        {
          "label": "A",
          "text": "Steatosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mallory-Denk bodies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Granulomas",
          "correct": false
        },
        {
          "label": "D",
          "text": "Onion-skinning",
          "correct": true
        }
      ],
      "correct_answer": "D. Onion-skinning",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-174600.jpg"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Steatosis, or the accumulation of fat within liver cells, is a feature more commonly associated with conditions like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, not PSC.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Mallory-Denk bodies are cytoplasmic inclusions found in liver cells, typically associated with alcoholic liver disease and not characteristic of PSC.</li><li>\u2022 Option B.</li><li>\u2022 Option C. Granulomas are aggregates of macrophages and are more typically associated with conditions such as sarcoidosis or granulomatous hepatitis, not specifically characteristic of PSC.</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Onion-skinning, characterized by concentric fibrosis and inflammation around bile ducts, is a characteristic histopathological feature of primary sclerosing cholangitis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c38faab8",
      "audio": ""
    },
    {
      "text": "A 17-year-old male presents with worsening academic performance, behavioral changes, slowed movements, and a slight tremor. Ophthalmological examination shows the following finding. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Parkinson's Disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Wilson Disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Juvenile Huntington's Disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Multiple Sclerosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Wilson Disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-174749.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The educational objective is to recognize the presentation and classic findings of Wilson Disease, particularly the presence of Kayser-Fleischer rings and a combination of hepatic and neuropsychiatric symptoms in a young patient.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1af145b7",
      "audio": ""
    },
    {
      "text": "What is the significance of the finding in the image?",
      "options": [
        {
          "label": "A",
          "text": "Hepatitis C infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Copper accumulation in Wilson Disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Iron overload in hemochromatosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bilirubin deposition in Dubin-Johnson syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Copper accumulation in Wilson Disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-175158.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hepatitis C infection can lead to liver dysfunction, but it does not cause Kayser-Fleischer rings or copper accumulation.</li><li>\u2022 Option A.</li><li>\u2022 Option C . Iron overload occurs in hemochromatosis, a different condition characterized by excessive iron deposition in the body, but it does not lead to Kayser-Fleischer rings.</li><li>\u2022 Option C</li><li>\u2022 Option D. Bilirubin deposition occurs in conditions like Dubin-Johnson syndrome, which can lead to liver dysfunction and jaundice, but not Kayser-Fleischer rings.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Kayser-Fleischer rings, a greenish-brown discoloration of the cornea periphery, is indicative of copper accumulation in Wilson Disease, which can cause liver dysfunction and neuropsychiatric symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0f136c42",
      "audio": ""
    },
    {
      "text": "Which of the following diagnostic tests is most appropriate for confirming Wilson\u2019s disease?",
      "options": [
        {
          "label": "A",
          "text": "Serum ceruloplasmin levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serum copper levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Liver biopsy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Genetic testing for ATP7B mutations",
          "correct": true
        }
      ],
      "correct_answer": "D. Genetic testing for ATP7B mutations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Serum ceruloplasmin levels are often low in Wilson Disease, but this finding is not specific and can be seen in other conditions or in carriers of the disease without clinical manifestations.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Serum copper levels can be elevated in Wilson Disease, but they can also be normal or low, making this test less reliable for diagnosis. Free copper levels (non-ceruloplasmin bound copper) can be more indicative but still lack the specificity of genetic testing.</li><li>\u2022 Option B.</li><li>\u2022 Option C. Liver biopsy can demonstrate copper accumulation and liver damage, and it can be useful in cases where the diagnosis is unclear. However, it is invasive and carries risks, making genetic testing a more definitive and less invasive option when available.</li><li>\u2022 Option C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Genetic testing for ATP7B mutations is the most definitive method for confirming a diagnosis of Wilson Disease, that directly identifies the genetic cause of the disorder.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29fa9137",
      "audio": ""
    },
    {
      "text": "What scoring system is commonly used for the initial assessment and diagnosis of Wilson Disease?",
      "options": [
        {
          "label": "A",
          "text": "Child-Pugh Score",
          "correct": false
        },
        {
          "label": "B",
          "text": "MELD Score",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nazer Score",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ranson's Criteria",
          "correct": false
        }
      ],
      "correct_answer": "C. Nazer Score",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A . The Child-Pugh Score is used to assess the prognosis of chronic liver disease, mainly cirrhosis, and to determine the required strength of treatment and the need for liver transplantation.</li><li>\u2022 Option A</li><li>\u2022 Option B . The MELD Score (Model for End-Stage Liver Disease) is used to prioritize patients for liver transplantation, based on the severity of chronic liver disease.</li><li>\u2022 Option B</li><li>\u2022 Option D. Ranson's Criteria are used to assess the severity of acute pancreatitis and predict its outcome.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The Nazer Score is a scoring system used for the initial assessment and diagnosis of Wilson Disease, incorporating clinical, biochemical, and histological parameters relevant to the disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "16d688b1",
      "audio": ""
    },
    {
      "text": "What is the mainstay of treatment for Wilson\u2019s disease?",
      "options": [
        {
          "label": "A",
          "text": "Iron chelation therapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Copper chelation therapy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Corticosteroids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ursodeoxycholic acid (UDCA)",
          "correct": false
        }
      ],
      "correct_answer": "B. Copper chelation therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Iron chelation therapy is used to treat conditions involving iron overload, such as hemochromatosis, not Wilson Disease, which involves copper accumulation.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Corticosteroids are not a primary treatment for Wilson Disease; they are more commonly used in conditions involving inflammation or autoimmune processes.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Ursodeoxycholic acid (UDCA) is used to improve liver function in certain liver diseases, such as primary biliary cirrhosis, but it is not a mainstay of treatment for Wilson Disease.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In copper chelation therapy, using agents such as penicillamine or trientine, is the mainstay of treatment for Wilson Disease to reduce copper accumulation in the body.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3226d2cd",
      "audio": ""
    },
    {
      "text": "A 35-year-old non-smoking male presents with exertional dyspnea and recurrent respiratory infections. Pulmonary function tests reveal airflow obstruction that does not significantly improve with bronchodilators. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic obstructive pulmonary disease (COPD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Asthma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alpha-1 antitrypsin (AAT) deficiency",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cystic fibrosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Alpha-1 antitrypsin (AAT) deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD): While COPD may present similarly to AAT deficiency, the lack of significant smoking history and the presence of recurrent respiratory infections suggest an alternative diagnosis such as AAT deficiency.</li><li>\u2022 Option A. Chronic obstructive pulmonary disease (COPD):</li><li>\u2022 Option B. Asthma : Asthma typically presents with reversible airflow obstruction and bronchial hyperresponsiveness, which may improve with bronchodilators, unlike the non-responsiveness seen in this case.</li><li>\u2022 Option B. Asthma</li><li>\u2022 Option D. Cystic fibrosis : Cystic fibrosis often presents with recurrent respiratory infections and obstructive lung disease but is associated with characteristic features such as pancreatic insufficiency and elevated sweat chloride levels, which are absent in AAT deficiency.</li><li>\u2022 Option D. Cystic fibrosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical presentation of AAT deficiency, includes early-onset emphysema in non-smokers and a lack of response to bronchodilators.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1485434",
      "audio": ""
    },
    {
      "text": "A 40-year-old male presents with a family history of early-onset emphysema. Pulmonary function tests reveal airflow obstruction that does not improve significantly with bronchodilators. What is the most appropriate initial diagnostic test?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-1 antitrypsin (AAT) level measurement",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chest X-ray",
          "correct": false
        },
        {
          "label": "C",
          "text": "High-resolution computed tomography (HRCT) scan of the chest",
          "correct": false
        },
        {
          "label": "D",
          "text": "Genetic testing for cystic fibrosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Alpha-1 antitrypsin (AAT) level measurement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Chest X-ray : While chest X-ray may reveal findings suggestive of emphysema, it is not specific for AAT deficiency and may not establish a definitive diagnosis.</li><li>\u2022 Option B. Chest X-ray</li><li>\u2022 Option C. High-resolution computed tomography (HRCT) scan of the chest : HRCT may show characteristic changes of emphysema, but it is not specific for AAT deficiency and may not be necessary as an initial diagnostic test.</li><li>\u2022 Option C. High-resolution computed tomography (HRCT) scan of the chest</li><li>\u2022 Option D. Genetic testing for cystic fibrosis : Genetic testing for cystic fibrosis is not indicated in the absence of clinical features suggestive of the condition, such as pancreatic insufficiency and elevated sweat chloride levels.</li><li>\u2022 Option D. Genetic testing for cystic fibrosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Alpha-1 antitrypsin (AAT) level measurement is the initial diagnostic test for suspected AAT deficiency helps in establishing a timely and accurate diagnosis to guide management decisions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1d355be",
      "audio": ""
    },
    {
      "text": "What is the most appropriate treatment to slow disease progression in emphysema due to alpha-1 antitrypsin (AAT) deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Long-acting beta-agonists (LABAs)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhaled corticosteroids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alpha-1 antitrypsin augmentation therapy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oxygen therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Alpha-1 antitrypsin augmentation therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Long-acting beta-agonists (LABAs) : LABAs may provide symptomatic relief but do not address the underlying deficiency of AAT and do not slow disease progression.</li><li>\u2022 Option A. Long-acting beta-agonists (LABAs)</li><li>\u2022 Option B. Inhaled corticosteroids : Inhaled corticosteroids may be used in patients with AAT deficiency and asthma or chronic bronchitis but are not effective in slowing the progression of emphysema.</li><li>\u2022 Option B. Inhaled corticosteroids</li><li>\u2022 Option D. Oxygen therapy : Oxygen therapy is used for symptomatic relief in patients with advanced emphysema and hypoxemia but does not address the underlying deficiency of AAT.</li><li>\u2022 Option D. Oxygen therapy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Alpha-1 antitrypsin (AAT) augmentation therapy helps in slowing disease progression in patients with AAT deficiency and emphysema.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f1be20d6",
      "audio": ""
    },
    {
      "text": "A 45-year-old male presents with fatigue, weakness, and joint pain. Physical examination reveals skin pigmentation as in the image below and hepatomegaly. Laboratory tests show elevated serum ferritin levels and increased transferrin saturation. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Wilson Disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hemochromatosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Alpha1 antitrypsin (A1AT) deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Systemic lupus erythematosus (SLE)",
          "correct": false
        }
      ],
      "correct_answer": "B. Hemochromatosis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-180615.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Wilson Disease involves copper accumulation and typically presents with liver dysfunction and neuropsychiatric symptoms, not primarily iron overload symptoms.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Alpha1 antitrypsin (A1AT) deficiency is a genetic disorder that can lead to liver disease and lung disease, but it is not associated with iron overload or the specific constellation of symptoms described.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organ systems and cause a wide range of symptoms, but it does not cause iron overload or the specific features described here.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The clinical features of hemochromatosis, includes fatigue, bronze skin pigmentation, hepatomegaly, and elevated serum ferritin levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93fa92fb",
      "audio": ""
    },
    {
      "text": "What diagnostic test is most appropriate for confirming the suspected diagnosis of hemochromatosis?",
      "options": [
        {
          "label": "A",
          "text": "Liver biopsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Genetic testing for HFE mutations",
          "correct": true
        },
        {
          "label": "C",
          "text": "Serum ceruloplasmin levels",
          "correct": false
        },
        {
          "label": "D",
          "text": "Abdominal ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "B. Genetic testing for HFE mutations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Liver biopsy can be used to assess the degree of liver damage and iron accumulation but is not the first-line test for diagnosing hemochromatosis due to its invasiveness.</li><li>\u2022 Option A.</li><li>\u2022 Option C. Serum ceruloplasmin levels are used in the evaluation of Wilson Disease, which involves copper metabolism, not iron.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Abdominal ultrasound can evaluate liver size and structure but is not specific for diagnosing hemochromatosis. It cannot directly detect iron overload.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Genetic testing for HFE mutations is the most direct and specific diagnostic test for confirming hereditary hemochromatosis, given its association with specific gene mutations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d4462724",
      "audio": ""
    },
    {
      "text": "What is the mainstay of treatment for reducing iron overload in hemochromatosis?",
      "options": [
        {
          "label": "A",
          "text": "Phlebotomy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Iron chelation therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Liver transplantation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Erythropoiesis-stimulating agents",
          "correct": false
        }
      ],
      "correct_answer": "A. Phlebotomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Iron chelation therapy is used primarily in patients who cannot undergo phlebotomy, such as those with anemia or heart complications, or in conditions of iron overload from repeated blood transfusions.</li><li>\u2022 Option B.</li><li>\u2022 Option C. Liver transplantation may be considered in advanced cases of hemochromatosis with severe liver damage, but it is not a treatment for iron overload per se.</li><li>\u2022 Option C.</li><li>\u2022 Option D. Erythropoiesis-stimulating agents are used to treat anemia, particularly in chronic kidney disease, and do not directly reduce iron overload.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Phlebotomy is the mainstay of treatment for reducing iron overload in patients with hemochromatosis, effectively lowering the total body iron burden through regular removal of blood.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "98b47865",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with alcohol use disorder undergoes successful endoscopic variceal ligation after variceal hemorrhage. To reduce rebleeding risk, the most appropriate additional treatment is :",
      "options": [
        {
          "label": "A",
          "text": "Immediate initiation of oral beta-blockers",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer a course of oral antibiotics",
          "correct": true
        },
        {
          "label": "C",
          "text": "Repeat endoscopic ligation in 24 hours",
          "correct": false
        },
        {
          "label": "D",
          "text": "Schedule for a transjugular intrahepatic portosystemic shunt (TIPS)",
          "correct": false
        }
      ],
      "correct_answer": "B. Administer a course of oral antibiotics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Administer a course of oral antibiotics (kindly check answer ????)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Immediate initiation of oral beta-blockers : While beta-blockers are important in the secondary prophylaxis of variceal bleeding, their immediate initiation is not as crucial as antibiotic prophylaxis.</li><li>\u2022 Option A. Immediate initiation of oral beta-blockers</li><li>\u2022 Option C. Repeat endoscopic ligation in 24 hours: Repeat endoscopic ligation is not typically performed within 24 hours unless there is evidence of rebleeding.</li><li>\u2022 Option C. Repeat endoscopic ligation in 24 hours:</li><li>\u2022 Option D. Schedule for a transjugular intrahepatic portosystemic shunt (TIPS):</li><li>\u2022 Option D. Schedule for a transjugular intrahepatic portosystemic shunt (TIPS):</li><li>\u2022 TIPS is reserved for patients who fail medical and endoscopic therapy and is not used as immediate prophylaxis after the first variceal bleed.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Antibiotic prophylaxis helps in preventing rebleeding and infections after an initial variceal hemorrhage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1e6a450",
      "audio": ""
    },
    {
      "text": "A 65-year-old male presents with dysphagia, regurgitation of undigested food, halitosis and history of recurrent aspiration pneumonia. Upper endoscopy reveals a pathology in the upper esophagus. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Achalasia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophageal stricture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Zenker's diverticulum",
          "correct": true
        },
        {
          "label": "D",
          "text": "Barrett's esophagus",
          "correct": false
        }
      ],
      "correct_answer": "C. Zenker's diverticulum",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Achalasia: Achalasia is characterized by the failure of the lower esophageal sphincter to relax and by aperistalsis of the esophagus, leading to dysphagia and regurgitation, but it does not involve the formation of a diverticulum.</li><li>\u2022 Option A. Achalasia:</li><li>\u2022 Option B. Esophageal stricture : An esophageal stricture typically presents with progressive dysphagia, particularly for solid foods, and is usually caused by chronic gastroesophageal reflux disease (GERD), radiation, or ingestion of caustic substances, but it does not cause a diverticulum.</li><li>\u2022 Option B. Esophageal stricture</li><li>\u2022 Option D. Barrett's esophagus: It is a condition where the lining of the esophagus is replaced by tissue similar to the lining of the intestine, usually as a result of chronic GERD. It is associated with an increased risk of esophageal adenocarcinoma but does not present with a diverticulum or the specific symptoms described.</li><li>\u2022 Option D. Barrett's esophagus:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Zenker's diverticulum is characterized by dysphagia, regurgitation of undigested food, halitosis, and the presence of a pulsion diverticulum just above the upper esophageal sphincter.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "47a1d7d7",
      "audio": ""
    },
    {
      "text": "A 40-year-old female presents with dysphagia, glossitis, and iron deficiency anemia. She reports a history of chronic oral ulcerations. What condition is most likely causing her symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Zenker's diverticulum",
          "correct": false
        },
        {
          "label": "B",
          "text": "Plummer-Vinson syndrome",
          "correct": true
        },
        {
          "label": "C",
          "text": "Barrett's esophagus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mallory-Weiss tear",
          "correct": false
        }
      ],
      "correct_answer": "B. Plummer-Vinson syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Plummer-Vinson syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Zenker's diverticulum: Zenker's diverticulum is a pharyngoesophageal diverticulum that can cause dysphagia and regurgitation of undigested food, but it is not associated with iron deficiency anemia, glossitis, or oral ulcerations.</li><li>\u2022 Option A. Zenker's diverticulum:</li><li>\u2022 Option C. Barrett's esophagus: Barrett's esophagus is a condition where the lining of the esophagus changes due to chronic gastroesophageal reflux disease (GERD), leading to an increased risk of esophageal adenocarcinoma. It typically does not present with iron deficiency anemia, glossitis, or oral ulcerations.</li><li>\u2022 Option C. Barrett's esophagus:</li><li>\u2022 Option D. Mallory-Weiss tear: A Mallory-Weiss tear is a tear in the mucosa near the gastroesophageal junction, typically caused by forceful retching or vomiting, leading to bleeding. It is not associated with iron deficiency anemia, glossitis, or chronic oral ulcerations as primary symptoms.</li><li>\u2022 Option D. Mallory-Weiss tear:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The combination of dysphagia, iron deficiency anemia, glossitis, and chronic oral ulcerations is indicative of Plummer-Vinson syndrome, a condition characterized by esophageal webs and increased risk for esophageal squamous cell carcinoma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e17118a4",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with dysphagia to solids, episodes of food impaction, a history of allergic conditions (allergic rhinitis and eczema), and upper endoscopy findings of linear furrows, white plaques, and concentric rings in the esophagus. What condition is most likely causing his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Gastroesophageal reflux disease (GERD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Eosinophilic esophagitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Barrett's esophagus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Infectious esophagitis",
          "correct": false
        }
      ],
      "correct_answer": "B. Eosinophilic esophagitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Gastroesophageal reflux disease: Gastroesophageal reflux disease (GERD) can cause dysphagia and esophageal changes, but the specific endoscopic findings described (linear furrows, white plaques, and concentric rings) are more characteristic of eosinophilic esophagitis.</li><li>\u2022 Option A. Gastroesophageal reflux disease:</li><li>\u2022 Option C. Barrett's esophagus: Barrett's esophagus involves changes in the esophageal lining due to chronic acid exposure from GERD, but it typically presents with metaplastic columnar epithelium rather than the findings described.</li><li>\u2022 Option C. Barrett's esophagus:</li><li>\u2022 Option D. Infectious esophagitis: Infectious esophagitis can cause dysphagia and might show ulcers or plaques on endoscopy, but it is more common in immunocompromised patients and does not typically present with the combination of findings seen in eosinophilic esophagitis.</li><li>\u2022 Option D. Infectious esophagitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Eosinophilic esophagitis is likely causing the symptoms in a young patient with dysphagia, a history of allergic conditions, and characteristic endoscopic findings of linear furrows, white plaques, and concentric rings in the esophagus.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cacb5fe6",
      "audio": ""
    },
    {
      "text": "A 53-year-old female presents with a one-year history of progressively worsening intermittent dysphagia to solids and liquids as well. She mentions episodes of waking up at night coughing and choking. She denies any significant weight loss. Barium swallow study reveals the following image. Esophageal manometry is most likely to show which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Decreased lower esophageal sphincter (LES) pressure",
          "correct": false
        },
        {
          "label": "B",
          "text": "Normal LES relaxation with swallowing",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased LES pressure with incomplete relaxation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hypercontractile esophageal peristalsis",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased LES pressure with incomplete relaxation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171841.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased LES pressure: This finding is more typical of gastroesophageal reflux disease (GERD) rather than achalasia.</li><li>\u2022 Option A. Decreased LES pressure:</li><li>\u2022 Option B. Normal LES relaxation with swallowing: This finding would be inconsistent with achalasia, where LES relaxation is impaired.</li><li>\u2022 Option B. Normal LES relaxation with swallowing:</li><li>\u2022 Option D. Hypercontractile esophageal peristalsis: This would suggest a disorder like Jackhammer esophagus rather than achalasia, which is characterized by aperistalsis.</li><li>\u2022 Option D. Hypercontractile esophageal peristalsis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The characteristic manometry findings of achalasia include : increased LES pressure and incomplete LES relaxation upon swallowing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "11bc468c",
      "audio": ""
    },
    {
      "text": "What is the most likely underlying pathophysiology in Achalasia cardia ?",
      "options": [
        {
          "label": "A",
          "text": "Autoimmune destruction of esophageal smooth muscle",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mechanical obstruction at the gastroesophageal junction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Degeneration of the myenteric plexus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hyperplasia of the esophageal mucosa",
          "correct": false
        }
      ],
      "correct_answer": "C. Degeneration of the myenteric plexus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Autoimmune destruction of esophageal smooth muscle: While some autoimmune conditions can affect the esophagus, direct autoimmune destruction of smooth muscle doesn't typically result in achalasia.</li><li>\u2022 Option A. Autoimmune destruction of esophageal smooth muscle:</li><li>\u2022 Option B. Mechanical obstruction at the gastroesophageal junction: This would suggest a condition like a tumor or stricture, not achalasia.</li><li>\u2022 Option B. Mechanical obstruction at the gastroesophageal junction:</li><li>\u2022 Option D. Hyperplasia of the esophageal mucosa: This is not associated with achalasia, which is a motility disorder.</li><li>\u2022 Option D. Hyperplasia of the esophageal mucosa:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Achalasia results from the degeneration of the myenteric plexus, leading to impaired LES relaxation and aperistalsis of the esophagus.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c61194a6",
      "audio": ""
    },
    {
      "text": "A 45-year-old female presents with a burning sensation in her chest after meals, particularly when lying down. She reports occasional regurgitation of acidic fluid into her mouth and has experienced hoarseness and chronic cough. What condition is most likely causing her symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Peptic ulcer disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophageal stricture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gastroesophageal reflux disease (GERD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Esophageal cancer",
          "correct": false
        }
      ],
      "correct_answer": "C. Gastroesophageal reflux disease (GERD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Gastroesophageal reflux disease (GERD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Peptic ulcer disease: Peptic ulcer disease may present with epigastric pain, which can be exacerbated by meals, but it is less likely to cause symptoms such as regurgitation or chronic cough.</li><li>\u2022 Option A. Peptic ulcer disease:</li><li>\u2022 Option B. Esophageal stricture: Esophageal strictures are characterized by narrowing of the esophageal lumen, often due to scarring or inflammation, and may cause dysphagia, but they do not typically present with heartburn or regurgitation.</li><li>\u2022 Option B. Esophageal stricture:</li><li>\u2022 Option D. Esophageal cancer: Esophageal cancer may present with dysphagia, weight loss, and other systemic symptoms, but it is less likely to cause typical GERD symptoms such as heartburn and regurgitation.</li><li>\u2022 Option D. Esophageal cancer:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The characteristic symptoms of gastroesophageal reflux disease (GERD), includes heartburn, regurgitation of acidic fluid, hoarseness, and chronic cough, particularly following meals and exacerbated by lying down.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "81b931d6",
      "audio": ""
    },
    {
      "text": "A 47-year-old man with 6 months of unresponsive epigastric pain, diarrhea, heartburn, no NSAID use, and mild epigastric tenderness presents with fasting serum gastrin levels of 1000 pg/mL and multiple duodenal and jejunal peptic ulcers on endoscopy. What is the most appropriate next step to confirm the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Secretin stimulation test",
          "correct": true
        },
        {
          "label": "B",
          "text": "Helicobacter pylori stool antigen test",
          "correct": false
        },
        {
          "label": "C",
          "text": "24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) test",
          "correct": false
        },
        {
          "label": "D",
          "text": "CT scan of the abdomen",
          "correct": false
        }
      ],
      "correct_answer": "A. Secretin stimulation test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Secretin stimulation test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Helicobacter pylori stool antigen test : While H. pylori infection is a common cause of peptic ulcers, the patient's high gastrin levels and multiple ulcers in the duodenum and jejunum suggest ZES, making this test less relevant for this case.</li><li>\u2022 Option B. Helicobacter pylori stool antigen test</li><li>\u2022 Option C. 24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) test : This test measures the breakdown product of serotonin and is used in the diagnosis of carcinoid syndrome, not ZES.</li><li>\u2022 Option C. 24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) test</li><li>\u2022 Option D. CT scan of the abdomen : Although CT can be used to localize gastrinomas, the diagnosis of ZES should be confirmed biochemically before imaging studies are performed.</li><li>\u2022 Option D. CT scan of the abdomen</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In a patient with multiple peptic ulcers and elevated fasting serum gastrin levels, the secretin stimulation test is the most appropriate next step to confirm the diagnosis of Zollinger-Ellison Syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1dd83083",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman with a history of hypertension and diabetes is on the ventilator since 72 hours in the ICU following a severe stroke. On the fourth day, the nurse reports the presence of coffee-ground material in the nasogastric tube. Which of the following interventions is most appropriate for the prevention of further gastrointestinal bleeding in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Initiation of oral sucralfate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous proton pump inhibitor (PPI) therapy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Administration of oral H2 receptor antagonist",
          "correct": false
        },
        {
          "label": "D",
          "text": "Placement of a transjugular intrahepatic portosystemic shunt (TIPS)",
          "correct": false
        }
      ],
      "correct_answer": "B. Intravenous proton pump inhibitor (PPI) therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Intravenous proton pump inhibitor (PPI) therapy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Initiation of oral sucralfate : While sucralfate can provide a protective barrier over gastrointestinal mucosa, it is less effective than PPIs for the prevention of stress-related gastrointestinal bleeding in critically ill patients.</li><li>\u2022 Option A. Initiation of oral sucralfate</li><li>\u2022 Option C. Administration of oral H2 receptor antagonist : H2 receptor antagonists reduce acid secretion and can be used for stress ulcer prophylaxis, but PPIs are generally preferred due to their superior acid suppression.</li><li>\u2022 Option C. Administration of oral H2 receptor antagonist</li><li>\u2022 Option D. Placement of a transjugular intrahepatic portosystemic shunt (TIPS) : TIPS is a procedure used to reduce portal hypertension, primarily in cirrhotic patients with variceal bleeding, and is not indicated for stress ulcer bleeding.</li><li>\u2022 Option D. Placement of a transjugular intrahepatic portosystemic shunt (TIPS)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In critically ill ICU patients at high risk for stress ulcers and gastrointestinal bleeding, such as those with severe neurological injuries or requiring mechanical ventilation, prophylactic intravenous PPI therapy is the most effective intervention to prevent further bleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e20b0176",
      "audio": ""
    },
    {
      "text": "A 44-year-old male with a history of dyspepsia is referred to gastroenterology for evaluation. What is the most appropriate initial test for Helicobacter pylori in the patient?",
      "options": [
        {
          "label": "A",
          "text": "Urea breath test",
          "correct": true
        },
        {
          "label": "B",
          "text": "Serologic antibody test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stool antigen test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endoscopic biopsy for histology",
          "correct": false
        }
      ],
      "correct_answer": "A. Urea breath test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Urea breath test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Serologic antibody test : This test can indicate past or present infection but cannot distinguish between the two, making it less useful for initial diagnosis or confirmation of eradication.</li><li>\u2022 Option B. Serologic antibody test</li><li>\u2022 Option C. Stool antigen test : Although this test is also non-invasive and has good sensitivity and specificity, the urea breath test is generally preferred due to its rapidity and convenience.</li><li>\u2022 Option C. Stool antigen test</li><li>\u2022 Option D. Endoscopic biopsy for histology : While accurate, endoscopy is invasive and not recommended as an initial test for patients without alarm symptoms.</li><li>\u2022 Option D. Endoscopic biopsy for histology</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For initial testing of Helicobacter pylori in patients with dyspepsia and no alarming features, the non-invasive and accurate urea breath test is the most appropriate choice.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c2c4fa3",
      "audio": ""
    },
    {
      "text": "Which test is most appropriate to diagnose H. pylori infection?",
      "options": [
        {
          "label": "A",
          "text": "Serologic antibody test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urea breath test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stool antigen test",
          "correct": true
        },
        {
          "label": "D",
          "text": "Endoscopic biopsy for histology",
          "correct": false
        }
      ],
      "correct_answer": "C. Stool antigen test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Stool antigen test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Serologic antibody test : It is not the best choice for diagnosis because it cannot differentiate between past and current infection.</li><li>\u2022 Option A. Serologic antibody test</li><li>\u2022 Option B. Urea breath test : This test is reliable but should be avoided if the patient is on proton pump inhibitors or bismuth, which can lead to false negatives.</li><li>\u2022 Option B. Urea breath test</li><li>\u2022 Option D. Endoscopic biopsy for histology : While accurate, it is invasive and typically reserved for patients with alarm symptoms or those in whom endoscopy is otherwise indicated.</li><li>\u2022 Option D. Endoscopic biopsy for histology</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The stool antigen test is the preferred non-invasive method for diagnosing active H. pylori infection, especially in patients taking iron supplements, which do not interfere with test results.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d8f88f0c",
      "audio": ""
    },
    {
      "text": "A 38-year-old man presents with a six-month history of nocturnal epigastric pain relieved by eating and antacids, with no alarming symptoms. To assess for past exposure to H. pylori, which test should be performed?",
      "options": [
        {
          "label": "A",
          "text": "Urea breath test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fecal antigen test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Serologic antibody test",
          "correct": true
        },
        {
          "label": "D",
          "text": "Endoscopic biopsy with rapid urease test",
          "correct": false
        }
      ],
      "correct_answer": "C. Serologic antibody test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Serologic antibody test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Urea breath test : This test is used to diagnose current active infection or to confirm eradication after treatment, but it is not used to determine past exposure.</li><li>\u2022 Option A. Urea breath test</li><li>\u2022 Option B. Fecal antigen test : Like the urea breath test, it is used to diagnose active infections and confirm eradication post-treatment.</li><li>\u2022 Option B. Fecal antigen test</li><li>\u2022 Option D. Endoscopic biopsy with rapid urease test : This is an invasive test for current infection, typically used if endoscopy is indicated for other reasons, such as alarm symptoms or failure of initial treatment.</li><li>\u2022 Option D. Endoscopic biopsy with rapid urease test</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The serologic antibody test can determine past exposure to H. pylori but cannot differentiate between current and past infection. It is not the test of choice for diagnosing active infection or for confirming eradication after treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e21a6f98",
      "audio": ""
    },
    {
      "text": "What is the most appropriate initial treatment regimen for H. pylori infection in a patient with no prior antibiotic exposure and no contraindications is triple therapy?",
      "options": [
        {
          "label": "A",
          "text": "Clarithromycin, amoxicillin, and omeprazole",
          "correct": true
        },
        {
          "label": "B",
          "text": "Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amoxicillin, ciprofloxacin, and ranitidine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metronidazole, ciprofloxacin, and lansoprazole",
          "correct": false
        }
      ],
      "correct_answer": "A. Clarithromycin, amoxicillin, and omeprazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Clarithromycin, amoxicillin, and omeprazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole : This quadruple therapy is an alternative, particularly in areas of high clarithromycin resistance or for patients with previous macrolide exposure.</li><li>\u2022 Option B. Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole</li><li>\u2022 Option C. Amoxicillin, ciprofloxacin, and ranitidine : This combination is not a standard regimen for H. pylori eradication and includes a fluoroquinolone and an H2 blocker, which is less effective than a proton pump inhibitor in this setting.</li><li>\u2022 Option C. Amoxicillin, ciprofloxacin, and ranitidine</li><li>\u2022 Option D. Metronidazole, ciprofloxacin, and lansoprazole : This regimen does not follow the recommended guidelines for H. pylori treatment due to the inclusion of ciprofloxacin, which is not a first-line agent for this infection.</li><li>\u2022 Option D. Metronidazole, ciprofloxacin, and lansoprazole</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The initial treatment for H. pylori infection should consist of triple therapy with a proton pump inhibitor (like omeprazole) and two antibiotics (clarithromycin and amoxicillin) for 14 days to effectively eradicate the infection and promote ulcer healing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22396949",
      "audio": ""
    },
    {
      "text": "A 48-year-old male hiker presents with several months of progressive weakness, joint pains, unexplained weight loss, intermittent diarrhea, recent episodes of uveitis and abdominal discomfort. Examination reveals hyperpigmentation of the skin, particularly around the eyes. Laboratory tests show anemia and a low serum albumin level. Endoscopic biopsy of the small intestine reveals numerous macrophages laden with periodic acid-Schiff (PAS)-positive granules in the lamina propria. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Sarcoidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Whipple's Disease",
          "correct": true
        },
        {
          "label": "C",
          "text": "Lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amyloidosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Whipple's Disease",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-094407.png"
      ],
      "explanation": "<p><strong>Ans. B) Whipple's Disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Sarcoidosis : This systemic granulomatous disease can cause similar systemic symptoms and hyperpigmentation, but it does not exhibit PAS-positive macrophages on intestinal biopsy.</li><li>\u2022 Option A. Sarcoidosis</li><li>\u2022 Option C. Lymphoma : While GI lymphoma may present with weight loss and abdominal pain, it does not show PAS-positive macrophages on biopsy.</li><li>\u2022 Option C. Lymphoma</li><li>\u2022 Option D. Amyloidosis : This condition can lead to systemic symptoms and gastrointestinal involvement, but the biopsy would show amyloid deposits, not PAS-positive macrophages.</li><li>\u2022 Option D. Amyloidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Whipple's disease should be suspected in patients with systemic symptoms, including arthralgias, gastrointestinal complaints, and hyperpigmentation, especially when intestinal biopsy shows PAS-positive macrophages.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd5047e0",
      "audio": ""
    },
    {
      "text": "Which of the following treatments is most appropriate for this Whipple\u2019s disease ?",
      "options": [
        {
          "label": "A",
          "text": "Long-term antibiotic therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole",
          "correct": true
        },
        {
          "label": "B",
          "text": "Gluten-free diet",
          "correct": false
        },
        {
          "label": "C",
          "text": "High-dose corticosteroids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chemotherapy",
          "correct": false
        }
      ],
      "correct_answer": "A. Long-term antibiotic therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Long-term antibiotic therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Gluten-free diet : This is the treatment for celiac disease, not Whipple's disease.</li><li>\u2022 Option B. Gluten-free diet</li><li>\u2022 Option C. High-dose corticosteroids : Steroids are not the primary treatment for Whipple's disease and are typically used for conditions with significant inflammation, like autoimmune diseases.</li><li>\u2022 Option C. High-dose corticosteroids</li><li>\u2022 Option D. Chemotherapy : Used for treating malignancies, not infectious diseases like Whipple's disease.</li><li>\u2022 Option D. Chemotherapy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The appropriate treatment for Whipple's disease involves initial antibiotic therapy, typically with ceftriaxone or penicillin G, followed by prolonged oral therapy with trimethoprim-sulfamethoxazole to eradicate the infection and prevent relapse.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f59c41ad",
      "audio": ""
    },
    {
      "text": "A 45-year-old female presents with chronic diarrhea, abdominal bloating, and vitamin B12 deficiency. She has a history of type 2 diabetes and underwent Roux-en-Y gastric bypass surgery 5 years ago. Her symptoms are partially relieved by antibiotics. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Lactose intolerance",
          "correct": false
        },
        {
          "label": "B",
          "text": "Irritable Bowel Syndrome (IBS)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Small Intestinal Bacterial Overgrowth (SIBO)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Celiac disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Small Intestinal Bacterial Overgrowth (SIBO)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Small Intestinal Bacterial Overgrowth (SIBO)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Lactose intolerance : Typically presents with symptoms after dairy consumption, but does not cause vitamin B12 deficiency or improve with antibiotics.</li><li>\u2022 Option A. Lactose intolerance</li><li>\u2022 Option B. Irritable Bowel Syndrome (IBS) : While IBS can cause similar symptoms, it does not lead to vitamin B12 deficiency and is not typically relieved by antibiotics.</li><li>\u2022 Option B. Irritable Bowel Syndrome (IBS)</li><li>\u2022 Option D. Celiac disease : Could explain the symptoms and vitamin deficiency, but the relief with antibiotics is more characteristic of SIBO.</li><li>\u2022 Option D. Celiac disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In patients with chronic gastrointestinal symptoms, vitamin deficiencies, and a history that predisposes to bacterial overgrowth, SIBO should be considered, especially when symptoms improve with antibiotic therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4d303ff",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman presents to the clinic with chronic diarrhea, weight loss, and fatigue following a 6-month volunteer trip to Southeast Asia. She reports a significant decrease in appetite and has noted her stools to be bulky and foul-smelling. Laboratory tests reveal iron-deficiency anemia and folate deficiency. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Celiac Disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Irritable Bowel Syndrome (IBS)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tropical Sprue",
          "correct": true
        },
        {
          "label": "D",
          "text": "Giardiasis",
          "correct": false
        }
      ],
      "correct_answer": "C. Tropical Sprue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tropical Sprue</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Celiac Disease : While celiac disease can cause similar gastrointestinal symptoms and malabsorption, it is not typically associated with travel to tropical regions.</li><li>\u2022 Option A. Celiac Disease</li><li>\u2022 Option B. Irritable Bowel Syndrome (IBS) : IBS primarily presents with abdominal discomfort and altered bowel habits but does not typically cause significant malabsorption or nutrient deficiencies.</li><li>\u2022 Option B. Irritable Bowel Syndrome (IBS)</li><li>\u2022 Option D. Giardiasis : This parasitic infection can cause diarrhea and malabsorption but is usually acute in nature and would likely resolve on its own or with appropriate treatment within a few weeks to months.</li><li>\u2022 Option D. Giardiasis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Tropical Sprue should be considered in patients with chronic diarrhea, malabsorption, and nutrient deficiencies, particularly if they have a history of extended travel or residency in tropical regions and symptoms persist despite returning to a non-tropical environment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "42969baf",
      "audio": ""
    },
    {
      "text": "A 5-year-old boy is brought to the pediatric clinic by his parents due to concerns about poor coordination, developmental delay and chronic diarrhea since infancy. Physical examination reveals a thin child with steatorrhea and acanthocytosis on blood smear. Laboratory tests indicate very low levels of cholesterol and triglycerides, and fat-soluble vitamin deficiencies are noted. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Cystic Fibrosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Celiac Disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Abetalipoproteinemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pancreatic Insufficiency",
          "correct": false
        }
      ],
      "correct_answer": "C. Abetalipoproteinemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Abetalipoproteinemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Cystic Fibrosis : This genetic disorder can cause malabsorption and growth delay but is more commonly associated with respiratory symptoms and does not typically present with acanthocytosis or the specific lipid profile seen in abetalipoproteinemia.</li><li>\u2022 Option A. Cystic Fibrosis</li><li>\u2022 Option B. Celiac Disease : While celiac disease can lead to malabsorption and growth problems, it does not cause the lipid abnormalities or acanthocytosis associated with abetalipoproteinemia.</li><li>\u2022 Option B. Celiac Disease</li><li>\u2022 Option D. Pancreatic Insufficiency : This condition can lead to steatorrhea and fat-soluble vitamin deficiencies but does not cause the abnormal lipid profile or acanthocytosis seen in abetalipoproteinemia.</li><li>\u2022 Option D. Pancreatic Insufficiency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In patients presenting with chronic diarrhea, failure to thrive, neurological symptoms, acanthocytosis, and very low levels of cholesterol and triglycerides, consider abetalipoproteinemia, especially if fat-soluble vitamin deficiencies are present.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "81305ea9",
      "audio": ""
    },
    {
      "text": "During an endoscopic examination of a 59-year-old male with a history of hematemesis, an ulcer in the duodenum is found to have a flat, pigmented spot at the base. There is no active bleeding or visible vessel. How should this ulcer be classified according to the Forrest classification?",
      "options": [
        {
          "label": "A",
          "text": "Forrest Ia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Forrest Ib",
          "correct": false
        },
        {
          "label": "C",
          "text": "Forrest IIb",
          "correct": false
        },
        {
          "label": "D",
          "text": "Forrest III",
          "correct": true
        }
      ],
      "correct_answer": "D. Forrest III",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Forrest III</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Forrest Ia: Ulcers have active spurting hemorrhage, which is not present in this patient.</li><li>\u2022 Option A. Forrest Ia:</li><li>\u2022 Option B. Forrest Ib: Ulcers have active oozing bleeding, not evident in this scenario.</li><li>\u2022 Option B. Forrest Ib:</li><li>\u2022 Option C. Forrest IIb: Ulcers have a non-bleeding visible vessel or an adherent clot, which is different from the described flat pigmented spot.</li><li>\u2022 Option C. Forrest IIb:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A duodenal ulcer with a flat pigmented spot and no active bleeding is Forrest III, which is associated with a low risk of rebleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2115a85f",
      "audio": ""
    },
    {
      "text": "A 25-year-old female with a history of recurrent abdominal pain and bloody diarrhea has undergone multiple colonoscopies over the past 3 years, all showing continuous inflammation of the mucosa extending from the rectum to the transverse colon. There is no evidence of granulomas on biopsy. Which feature is most suggestive of her underlying condition?",
      "options": [
        {
          "label": "A",
          "text": "Skip lesions",
          "correct": false
        },
        {
          "label": "B",
          "text": "Granuloma formation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Continuous mucosal involvement",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transmural inflammation",
          "correct": false
        }
      ],
      "correct_answer": "C. Continuous mucosal involvement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Continuous mucosal involvement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Skip lesions : Characteristic of Crohn's Disease, which involves patchy areas of inflammation separated by healthy tissue along the digestive tract.</li><li>\u2022 Option A. Skip lesions</li><li>\u2022 Option B. Granuloma formation : Also more typical of Crohn's Disease, where non-caseating granulomas can often be found on biopsy.</li><li>\u2022 Option B. Granuloma formation</li><li>\u2022 Option D. Transmural inflammation : Suggestive of Crohn's Disease, as it involves the entire thickness of the bowel wall, unlike the superficial involvement seen in Ulcerative Colitis.</li><li>\u2022 Option D. Transmural inflammation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Continuous mucosal involvement without granulomas, especially from the rectum to more proximal parts of the colon, suggests Ulcerative Colitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c4210b2f",
      "audio": ""
    },
    {
      "text": "A 36-year-old woman with a diagnosis of Irritable Bowel Syndrome (IBS) predominantly with constipation (IBS-C) can be prescribed which drug to alleviate constipation and abdominal discomfort. Which of the following is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Lubiprostone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Loperamide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Broad-spectrum antibiotics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gluten-free diet",
          "correct": false
        }
      ],
      "correct_answer": "A. Lubiprostone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Lubiprostone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Loperamide : Primarily used to manage diarrhea (IBS-D) due to its antidiarrheal effects, not suitable for IBS-C.</li><li>\u2022 Option B. Loperamide</li><li>\u2022 Option C. Broad-spectrum antibiotics : May be used in specific cases like Small Intestinal Bacterial Overgrowth (SIBO), but not typically for IBS-C without evidence of SIBO.</li><li>\u2022 Option C. Broad-spectrum antibiotics</li><li>\u2022 Option D. Gluten-free diet : While some patients with IBS may report sensitivity to gluten, a gluten-free diet is not a standard treatment for IBS-C and is more specific to conditions like celiac disease.</li><li>\u2022 Option D. Gluten-free diet</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For IBS-C, when dietary fiber is insufficient, medications like lubiprostone that enhance intestinal fluid secretion can be effective in managing symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56ecdd03",
      "audio": ""
    },
    {
      "text": "Which medication would be most appropriate to add in the management plan of severe IBS-D in men and women when other treatments have not been effective?",
      "options": [
        {
          "label": "A",
          "text": "Alosetron",
          "correct": true
        },
        {
          "label": "B",
          "text": "Psyllium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Omeprazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metformin",
          "correct": false
        }
      ],
      "correct_answer": "A. Alosetron",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Alosetron</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Psyllium : A soluble fiber that can help manage both IBS-C and IBS-D, but might not be sufficient for severe IBS-D cases.</li><li>\u2022 Option B. Psyllium</li><li>\u2022 Option C. Omeprazole : A proton pump inhibitor used for acid-related disorders, not typically used for IBS-D.</li><li>\u2022 Option C. Omeprazole</li><li>\u2022 Option D. Metformin : Used in the management of type 2 diabetes, not IBS-D.</li><li>\u2022 Option D. Metformin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For patients with severe IBS-D not adequately managed by dietary modifications, alosetron can be considered under a risk management program due to its efficacy in reducing diarrhea and bowel urgency.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2239b5e5",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents with abdominal pain, diarrhea, and a recent onset of fever. She has a history of mouth ulcers. Imaging studies reveal thickening of the terminal ileum and the presence of a fistula. Which of the following diagnoses is most consistent with these findings?",
      "options": [
        {
          "label": "A",
          "text": "Crohn's Disease",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ulcerative Colitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diverticulitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gastroenteritis",
          "correct": false
        }
      ],
      "correct_answer": "A. Crohn's Disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Crohn's Disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Ulcerative Colitis : Typically involves continuous inflammation of the colon starting from the rectum, without fistulas or mouth ulcers.</li><li>\u2022 Option B. Ulcerative Colitis</li><li>\u2022 Option C. Diverticulitis : Involves the inflammation or infection of diverticula in the colon, not commonly associated with terminal ileum involvement or fistula formation in this context.</li><li>\u2022 Option C. Diverticulitis</li><li>\u2022 Option D. Gastroenteritis : Generally presents with acute onset of diarrhea and vomiting due to infection, not typically associated with chronic inflammation, thickening of the ileum, or fistulas.</li><li>\u2022 Option D. Gastroenteritis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Terminal ileum involvement, fistula formation, and mouth ulcers strongly indicate Crohn's Disease among inflammatory bowel diseases.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1a5784e4",
      "audio": ""
    },
    {
      "text": "A 33-year-old male with a diagnosis of Crohn's Disease presents with moderate to severe flare-up symptoms despite oral corticosteroid therapy. His medical history includes a partial ileal resection. Which of the following is the most appropriate next step in his management?",
      "options": [
        {
          "label": "A",
          "text": "Increase the dose of oral corticosteroids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Initiate 5-aminosalicylic acid (5-ASA) therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Start infliximab therapy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Surgical resection of affected segments",
          "correct": false
        }
      ],
      "correct_answer": "C. Start infliximab therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Start infliximab therapy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Increase the dose of oral corticosteroids : Not advisable due to the risk of steroid dependency and side effects, particularly in cases unresponsive to initial corticosteroid therapy.</li><li>\u2022 Option A. Increase the dose of oral corticosteroids</li><li>\u2022 Option B. Initiate 5-aminosalicylic acid (5-ASA) therapy : 5-ASA is more commonly used in mild to moderate ulcerative colitis and has limited efficacy in Crohn's Disease, especially in moderate to severe cases.</li><li>\u2022 Option B. Initiate 5-aminosalicylic acid (5-ASA) therapy</li><li>\u2022 Option D. Surgical resection of affected segments : Surgery may be considered for complications or disease refractory to medical therapy, but it is not the first step following corticosteroid failure.</li><li>\u2022 Option D. Surgical resection of affected segments</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In moderate to severe Crohn's Disease unresponsive to corticosteroids, anti-TNF agents like infliximab are effective in inducing and maintaining remission.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ef18634",
      "audio": ""
    },
    {
      "text": "A 26-year-old woman with Crohn's Disease has mild ileocolic involvement controlled with budesonide. She is planning to conceive. What is the most appropriate management to maintain remission during pregnancy?",
      "options": [
        {
          "label": "A",
          "text": "Discontinue all medications",
          "correct": false
        },
        {
          "label": "B",
          "text": "Switch to oral mesalamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Continue budesonide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Initiate azathioprine",
          "correct": false
        }
      ],
      "correct_answer": "C. Continue budesonide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Continue budesonide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Discontinue all medications : Discontinuing effective treatment could lead to a flare-up, which poses a greater risk to both the mother and the fetus than the medication itself.</li><li>\u2022 Option A. Discontinue all medications</li><li>\u2022 Option B. Switch to oral mesalamine : While mesalamine is generally safe in pregnancy, there's no need to switch if budesonide is effectively controlling the disease.</li><li>\u2022 Option B. Switch to oral mesalamine</li><li>\u2022 Option D. Initiate azathioprine : Azathioprine can be used during pregnancy for IBD management, but it's typically reserved for more severe disease or when other treatments are ineffective.</li><li>\u2022 Option D. Initiate azathioprine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Budesonide can be safely continued during pregnancy to maintain remission in patients with mild Crohn's Disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "202da6f0",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of polycythemia vera presents with gradual onset of diffuse abdominal pain, bloating, and diarrhea over the past week. She denies any cardiac history. Laboratory tests show elevated white blood cells and lactate. CT abdomen reveals venous dilatation and edema in the bowel wall without arterial occlusion. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute mesenteric ischemia due to arterial embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic mesenteric ischemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mesenteric venous thrombosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Nonocclusive mesenteric ischemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Mesenteric venous thrombosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Mesenteric venous thrombosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Acute mesenteric ischemia due to arterial embolism : Typically presents suddenly with severe pain, often in patients with a cardiac source of emboli.</li><li>\u2022 Option A. Acute mesenteric ischemia due to arterial embolism</li><li>\u2022 Option B. Chronic mesenteric ischemia : Presents with postprandial pain and weight loss over months to years, not with acute symptoms.</li><li>\u2022 Option B. Chronic mesenteric ischemia</li><li>\u2022 Option D. Nonocclusive mesenteric ischemia : Occurs in low-flow states such as heart failure or sepsis, and is characterized by diffuse pain without a clear occlusive source on imaging.</li><li>\u2022 Option D. Nonocclusive mesenteric ischemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Mesenteric venous thrombosis should be considered in patients with a hypercoagulable state presenting with gradual onset of abdominal pain and specific CT findings, even without arterial occlusion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8dd8550",
      "audio": ""
    },
    {
      "text": "An 82-year-old man with a history of heart failure and recent myocardial infarction is admitted to the ICU for management of cardiogenic shock. He subsequently develops diffuse abdominal pain,bloody diarrhea and hypotension. Abdominal imaging shows diffuse small bowel wall thickening with patent mesenteric vessels. What is the most likely cause of his abdominal symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Acute mesenteric ischemia due to arterial embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic mesenteric ischemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mesenteric venous thrombosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonocclusive mesenteric ischemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Nonocclusive mesenteric ischemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Nonocclusive mesenteric ischemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Explanation :</li><li>\u2022 Explanation</li><li>\u2022 Option A. Acute mesenteric ischemia due to arterial embolism : Typically presents suddenly in patients with a source for emboli (e.g., atrial fibrillation), not primarily associated with low-flow states.</li><li>\u2022 Option A. Acute mesenteric ischemia due to arterial embolism</li><li>\u2022 Option B. Chronic mesenteric ischemia : Manifests with postprandial abdominal pain and weight loss over months to years, not acutely in the setting of cardiogenic shock.</li><li>\u2022 Option B. Chronic mesenteric ischemia</li><li>\u2022 Option C. Mesenteric venous thrombosis : Presents with gradual onset abdominal pain, often associated with hypercoagulable states, and would show venous occlusion on imaging.</li><li>\u2022 Option C. Mesenteric venous thrombosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In patients with systemic low-flow states, such as cardiogenic shock, presenting with acute abdominal symptoms and diffuse bowel wall changes without vessel occlusion, consider nonocclusive mesenteric ischemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "03888fa0",
      "audio": ""
    },
    {
      "text": "In a 52-year-old man with a history of alcohol abuse presenting with hematemesis, jaundice, ascites, palmar erythema, spider angiomata, thrombocytopenia, and prolonged PT/INR, what is the most appropriate diagnostic procedure to identify the bleeding source?",
      "options": [
        {
          "label": "A",
          "text": "Abdominal ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophagogastroduodenoscopy (EGD)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Contrast-enhanced CT scan of the abdomen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Barium swallow study",
          "correct": false
        }
      ],
      "correct_answer": "B. Esophagogastroduodenoscopy (EGD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Esophagogastroduodenoscopy (EGD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Abdominal ultrasound: Abdominal ultrasound is useful for evaluating the liver, spleen, and portal vein, which could help in assessing the chronic liver disease but is not the immediate test for active upper gastrointestinal bleeding.</li><li>\u2022 Option A. Abdominal ultrasound:</li><li>\u2022 Option C. Contrast-enhanced CT scan of the abdomen: Contrast-enhanced CT scan of the abdomen is helpful in the evaluation of abdominal structures and can provide information about the liver and spleen, but it is not the first-line diagnostic tool for an active variceal bleed.</li><li>\u2022 Option C. Contrast-enhanced CT scan of the abdomen:</li><li>\u2022 Option D. Barium swallow study: A barium swallow study may be used to evaluate structural abnormalities of the esophagus and stomach, but it is contraindicated in the setting of an active bleed as it can interfere with endoscopic therapeutic procedures.</li><li>\u2022 Option D. Barium swallow study:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 EGD is the immediate and most appropriate next step in the diagnosis and potential treatment of variceal bleeding in a patient with signs of portal hypertension and cirrhosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f895ef4c",
      "audio": ""
    },
    {
      "text": "For a 50-year-old male with cirrhosis due to hepatitis C presenting with acute hematemesis, jaundice, ascites, and palmar erythema, who has been stabilized with IV fluids, the best immediate pharmacotherapy is:",
      "options": [
        {
          "label": "A",
          "text": "Oral propranolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous octreotide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Intravenous ceftriaxone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oral omeprazole",
          "correct": false
        }
      ],
      "correct_answer": "B. Intravenous octreotide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Intravenous octreotide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Oral propranolol: Is used in the primary prevention of variceal bleeding, not in the acute setting.</li><li>\u2022 Option A. Oral propranolol:</li><li>\u2022 Option C. Intravenous ceftriaxone: Is indicated for infection prophylaxis in cirrhotic patients with gastrointestinal bleeding, but it is not the primary treatment for the bleed itself.</li><li>\u2022 Option C. Intravenous ceftriaxone:</li><li>\u2022 Option D. Oral omeprazole: Is a proton pump inhibitor that may help with peptic ulcers but is not the first-line treatment for acute variceal bleeding.</li><li>\u2022 Option D. Oral omeprazole:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Intravenous octreotide is the initial pharmacological treatment in the acute management of variceal bleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e838fc7f",
      "audio": ""
    },
    {
      "text": "A 56-year-old man with cirrhosis is admitted to the hospital with a variceal bleed. He has been resuscitated and received octreotide and endoscopic band ligation. The next day, he develops melena. His hemoglobin has dropped from 8.5 g/dL on admission to 7.8 g/dL. What is the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Start a proton pump inhibitor (PPI) infusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arrange for an urgent repeat endoscop",
          "correct": true
        },
        {
          "label": "C",
          "text": "Perform a tagged red blood cell scan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure",
          "correct": false
        }
      ],
      "correct_answer": "B. Arrange for an urgent repeat endoscop",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Arrange for an urgent repeat endoscopy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Start a proton pump inhibitor (PPI) infusion: Proton pump inhibitor (PPI) infusion is adjunctive therapy for peptic ulcer disease but would not be the most appropriate next step for suspected ongoing variceal bleeding.</li><li>\u2022 Option A. Start a proton pump inhibitor (PPI) infusion:</li><li>\u2022 Option C. Perform a tagged red blood cell scan : A tagged red blood cell scan is a diagnostic procedure to localize sites of slow gastrointestinal bleeding but is not appropriate for acute rebleeding where endoscopy is indicated.</li><li>\u2022 Option C. Perform a tagged red blood cell scan</li><li>\u2022 Option D. Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure: A transjugular intrahepatic portosystemic shunt (TIPS) is considered if endoscopic treatment fails or is not possible; it is not the immediate next step after a drop in hemoglobin without first reassessing endoscopically.</li><li>\u2022 Option D. Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An urgent repeat endoscopy is indicated in a patient with cirrhosis who develops signs of ongoing variceal bleeding post-initial endoscopic treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6e9a541",
      "audio": ""
    },
    {
      "text": "A 22-year-old male presents with a 6-month history of bloody diarrhea, abdominal pain, and weight loss. Colonoscopy shows continuous mucosal inflammation and ulceration limited to the rectum and sigmoid colon. Biopsy findings include crypt abscesses and mucosal inflammation. Which condition do these findings most likely suggest?",
      "options": [
        {
          "label": "A",
          "text": "Crohn's Disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ulcerative Colitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Infectious Colitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ischemic Colitis",
          "correct": false
        }
      ],
      "correct_answer": "B. Ulcerative Colitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Ulcerative Colitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Crohn's Disease : Typically presents with transmural inflammation and can affect any part of the gastrointestinal tract from mouth to anus, often with \"skip lesions.\"</li><li>\u2022 Option A. Crohn's Disease</li><li>\u2022 Option C. Infectious Colitis : Usually has a more acute onset and is associated with infectious pathogens; biopsy might show inflammation but not typically crypt abscesses.</li><li>\u2022 Option C. Infectious Colitis</li><li>\u2022 Option D. Ischemic Colitis : Generally occurs in older patients and involves the splenic flexure and descending colon; histology would show ischemic changes rather than crypt abscesses.</li><li>\u2022 Option D. Ischemic Colitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Continuous colonic inflammation with crypt abscesses, particularly in the rectum and sigmoid colon, suggests Ulcerative Colitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "582be4dc",
      "audio": ""
    },
    {
      "text": "Which of the following is the most critical diagnostic criterion for toxic megacolon ?",
      "options": [
        {
          "label": "A",
          "text": "Presence of colonic dilation >6 cm on imaging",
          "correct": true
        },
        {
          "label": "B",
          "text": "History of constipation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fever and tachycardia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Electrolyte imbalances",
          "correct": false
        }
      ],
      "correct_answer": "A. Presence of colonic dilation >6 cm on imaging",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Presence of colonic dilation >6 cm on imaging</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. History of constipation: While constipation can be a symptom associated with various gastrointestinal conditions, it is not a specific or critical diagnostic criterion for toxic megacolon. Toxic megacolon is more directly identified by imaging showing colonic dilation and systemic signs of toxicity.</li><li>\u2022 Option B. History of constipation:</li><li>\u2022 Option C. Fever and tachycardia: Fever and tachycardia are signs of systemic inflammation and toxicity. They can be present in toxic megacolon but are not specific to this condition. They can occur in various infectious and inflammatory diseases and are not definitive for diagnosing toxic megacolon.</li><li>\u2022 Option C. Fever and tachycardia:</li><li>\u2022 Option D. Electrolyte imbalances: Electrolyte imbalances can occur in many gastrointestinal disorders, including severe diarrhea or vomiting, and can be a consequence of toxic megacolon due to fluid shifts and systemic illness. However, they are not specific diagnostic criteria for toxic megacolon. The primary diagnostic criterion remains colonic dilation >6 cm on imaging.</li><li>\u2022 Option D. Electrolyte imbalances:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Colonic dilation >6 cm on imaging is a key diagnostic criterion for toxic megacolon, especially in patients with underlying inflammatory bowel disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "676575ae",
      "audio": ""
    },
    {
      "text": "According to the Forrest classification, a gastric ulcer on the lesser curvature of the stomach is classified as ?",
      "options": [
        {
          "label": "A",
          "text": "Forrest Ia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Forrest Ib",
          "correct": false
        },
        {
          "label": "C",
          "text": "Forrest IIa",
          "correct": true
        },
        {
          "label": "D",
          "text": "Forrest IIb",
          "correct": false
        }
      ],
      "correct_answer": "C. Forrest IIa",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Forrest IIa</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Forrest Ia: Represents active arterial bleeding, which is not described in the scenario.</li><li>\u2022 Option A. Forrest Ia:</li><li>\u2022 Option B. Forrest Ib: Indicates an active bleed but with a slower, oozing vessel, also not described here.</li><li>\u2022 Option B. Forrest Ib:</li><li>\u2022 Option D. Forrest IIb: It is characterized by an ulcer with an adherent clot, not a visible vessel.</li><li>\u2022 Option D. Forrest IIb:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A gastric ulcer with a visible non-bleeding vessel according to the Forrest classification (Forrest IIa), indicates a high risk of rebleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c68a707d",
      "audio": ""
    },
    {
      "text": "A 55-year-old male presents with intermittent dysphagia to solids, particularly meat, which improves with swallowing water. He denies any history of heartburn or regurgitation. Upper endoscopy reveals a lesion at the gastroesophageal junction. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Achalasia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophageal stricture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Schatzki ring",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mallory-Weiss tear",
          "correct": false
        }
      ],
      "correct_answer": "C. Schatzki ring",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171136.png"
      ],
      "explanation": "<p><strong>Ans. C) Schatzki ring</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Achalasia: Achalasia typically presents with progressive dysphagia to both solids and liquids, regurgitation of undigested food, and sometimes chest pain, due to the failure of the lower esophageal sphincter to relax and absence of esophageal peristalsis.</li><li>\u2022 Option A. Achalasia:</li><li>\u2022 Option B. Esophageal stricture: An esophageal stricture usually results from chronic gastroesophageal reflux disease (GERD) and presents with gradual onset of dysphagia to solids, but it does not present as a circumferential ring at the gastroesophageal junction.</li><li>\u2022 Option B. Esophageal stricture:</li><li>\u2022 Option D. Mallory-Weiss tear: A Mallory-Weiss tear is a longitudinal tear in the mucosa at the gastroesophageal junction or in the stomach, usually caused by severe retching or vomiting, leading to hematemesis, not dysphagia.</li><li>\u2022 Option D. Mallory-Weiss tear:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presentation of intermittent dysphagia to solids, particularly meat, that improves with water and the finding of a circumferential ring at the gastroesophageal junction on endoscopy, is indicative of a Schatzki ring.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c59e73db",
      "audio": ""
    },
    {
      "text": "A 50-year-old female presents with dysphagia and chest pain. She describes the chest pain as intense and squeezing, radiating to her back and relieved with antacids. Esophageal manometry reveals high-amplitude peristaltic contractions with a distal esophageal spasm. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Achalasia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diffuse esophageal spasm",
          "correct": false
        },
        {
          "label": "C",
          "text": "Jackhammer esophagus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Nutcracker esophagus",
          "correct": false
        }
      ],
      "correct_answer": "C. Jackhammer esophagus",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171523.png"
      ],
      "explanation": "<p><strong>Ans. C) Jackhammer esophagus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Achalasia: Achalasia is characterized by the failure of the lower esophageal sphincter (LES) to relax and the absence of normal esophageal peristalsis, leading to symptoms of dysphagia and regurgitation, which is not consistent with the described manometry findings.</li><li>\u2022 Option A. Achalasia:</li><li>\u2022 Option B. Diffuse esophageal spasm: Diffuse esophageal spasm presents with intermittent contractions of the esophagus that are non-peristaltic, leading to chest pain and dysphagia, but the contractions are not typically described as high amplitude as in Jackhammer esophagus.</li><li>\u2022 Option B. Diffuse esophageal spasm:</li><li>\u2022 Option D. Nutcracker esophagus : Nutcracker esophagus is characterized by high-amplitude peristaltic contractions in the distal esophagus, but unlike Jackhammer esophagus, the contractions maintain a normal duration, and the term \"nutcracker\" is used to describe the strong squeezing nature of the contractions.</li><li>\u2022 Option D. Nutcracker esophagus</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Jackhammer esophagus is characterized by high-amplitude, prolonged peristaltic contractions in the distal esophagus, as observed on esophageal manometry, leading to symptoms of dysphagia and intense chest pain that may be relieved with antacids.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "95a9b97f",
      "audio": ""
    },
    {
      "text": "A 45-year-old male presents with heatburn and dysphagia to solids and liquids, along with regurgitation of undigested food. Barium swallow shows image as below. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Gastroesophageal reflux disease (GERD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophageal stricture",
          "correct": false
        },
        {
          "label": "C",
          "text": "Achalasia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Diffuse esophageal spasm",
          "correct": false
        }
      ],
      "correct_answer": "C. Achalasia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171654.png"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171712.png"
      ],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Gastroesophageal reflux disease (GERD): GERD typically presents with heartburn and regurgitation, and may cause esophageal strictures, but it does not involve impaired esophageal sphincter relaxation.</li><li>\u2022 Option A. Gastroesophageal reflux disease (GERD):</li><li>\u2022 Option B. Esophageal stricture: Esophageal strictures are characterized by narrowing of the esophageal lumen, often due to scarring or inflammation, and may present with dysphagia.</li><li>\u2022 Option B. Esophageal stricture:</li><li>\u2022 Option D. Diffuse esophageal spasm: Diffuse esophageal spasm presents with uncoordinated, simultaneous contractions of the esophagus, leading to chest pain and dysphagia, but it does not involve impaired lower esophageal sphincter relaxation.</li><li>\u2022 Option D. Diffuse esophageal spasm:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Achalasia is characterized by impaired relaxation of the lower esophageal sphincter and absent peristalsis in the esophageal body, leading to dysphagia and regurgitation. The classic radiographic finding on barium swallow is a dilated esophagus with a bird's beak appearance at the gastroesophageal junction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e597e22b",
      "audio": ""
    },
    {
      "text": "A 39-year-old woman with a history of severe recurrent peptic ulcers despite high-dose PPIs, watery diarrhea, weight loss, previous parathyroid adenoma, hypercalcemia, and elevated fasting serum gastrin levels is evaluated. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Celiac disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Zollinger-Ellison Syndrome (ZES)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Crohn's disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gastric cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Zollinger-Ellison Syndrome (ZES)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Zollinger-Ellison Syndrome (ZES)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Celiac disease : Characterized by malabsorption and gastrointestinal symptoms due to gluten sensitivity, celiac disease can cause peptic ulcer-like symptoms but would not explain the hypercalcemia or markedly elevated gastrin levels.</li><li>\u2022 Option A. Celiac disease</li><li>\u2022 Option C. Crohn's disease : While Crohn's can affect any part of the gastrointestinal tract and cause ulcerations, it does not typically present with hypergastrinemia or hypercalcemia.</li><li>\u2022 Option C. Crohn's disease</li><li>\u2022 Option D. Gastric cancer : While gastric cancer can present with ulcers and weight loss, the markedly elevated gastrin levels and hypercalcemia are more indicative of ZES, especially in the context of a MEN1 syndrome background.</li><li>\u2022 Option D. Gastric cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In a patient with recurrent peptic ulcers resistant to treatment, episodes of watery diarrhea, hypercalcemia, and a markedly elevated fasting serum gastrin level, Zollinger-Ellison Syndrome should be considered, particularly if there is a history of endocrine tumors suggestive of MEN1 syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "175341f8",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate next step in the management of patient diagnosed with GERD who has not responded to initial treatment measures such as antacids ?",
      "options": [
        {
          "label": "A",
          "text": "Start a proton pump inhibitor (PPI) trial",
          "correct": false
        },
        {
          "label": "B",
          "text": "Perform Upper Gastrointestinal Endoscopy (UGIE)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Order a 24-hour esophageal pH monitoring",
          "correct": false
        },
        {
          "label": "D",
          "text": "Recommend lifestyle modifications and reassess in 6 months",
          "correct": false
        }
      ],
      "correct_answer": "B. Perform Upper Gastrointestinal Endoscopy (UGIE)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Perform Upper Gastrointestinal Endoscopy (UGIE)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Start a proton pump inhibitor (PPI) trial: Starting a PPI trial is a reasonable initial approach for suspected GERD but is less appropriate in this case because the patient has not responded to antacids, and there is a need for diagnostic evaluation.</li><li>\u2022 Option A. Start a proton pump inhibitor (PPI) trial:</li><li>\u2022 Option C. 24-hour esophageal pH monitoring : 24-hour esophageal pH monitoring is the gold standard for diagnosing GERD but is typically reserved for cases where the diagnosis is unclear after endoscopy or when evaluating the efficacy of therapy in complicated cases.</li><li>\u2022 Option C. 24-hour esophageal pH monitoring</li><li>\u2022 Option D. Recommend lifestyle modifications and reassess in 6 months:</li><li>\u2022 Option D. Recommend lifestyle modifications and reassess in 6 months:</li><li>\u2022 Lifestyle modifications are recommended for all patients with GERD, but solely recommending this without further evaluation or treatment is inadequate for a patient with persistent symptoms despite over-the-counter treatments.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In patients with GERD symptoms not responding to initial treatments or presenting with alarm features, UGIE is indicated to evaluate for complications and rule out other diagnoses.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a3ae99fd",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate next step to evaluate symptoms in a patient with GERD who has persistent symptoms despite optimized PPI therapy and in whom other complications have been ruled out through UGIE, 24-hour esophageal pH monitoring?Which of the following is the most appropriate next step to evaluate symptoms in a patient with GERD who has persistent symptoms despite optimized PPI therapy and in whom other complications have been ruled out through UGIE, 24-hour esophageal pH monitoring?",
      "options": [
        {
          "label": "A",
          "text": "Order a barium swallow test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Perform a repeat UGIE",
          "correct": false
        },
        {
          "label": "C",
          "text": "Order a 24-hour esophageal pH monitoring",
          "correct": true
        },
        {
          "label": "D",
          "text": "Initiate a trial of H2 receptor antagonists",
          "correct": false
        }
      ],
      "correct_answer": "C. Order a 24-hour esophageal pH monitoring",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Order a 24-hour esophageal pH monitoring</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Barium swallow test: A barium swallow test may be useful in evaluating anatomical abnormalities like a hiatal hernia but is less useful for assessing ongoing reflux in a patient already diagnosed with GERD.</li><li>\u2022 Option A. Barium swallow test:</li><li>\u2022 Option B. Perform a repeat UGIE: Repeat UGIE might be considered if there were new or worsening symptoms suggesting complications, but it is not the best next step for evaluating treatment-resistant GERD without new alarm features.</li><li>\u2022 Option B. Perform a repeat UGIE:</li><li>\u2022 Option D. Initiate a trial of H2 receptor antagonists: Initiating a trial of H2 receptor antagonists may be considered as an adjunctive therapy to PPIs in some cases, but it's more appropriate to assess the current treatment's effectiveness with pH monitoring before changing the therapeutic approach.</li><li>\u2022 Option D. Initiate a trial of H2 receptor antagonists:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For patients with GERD not responding to optimized PPI therapy and without alarm features, 24-hour esophageal pH monitoring is the most appropriate next step to assess the adequacy of acid suppression and correlate symptoms with reflux events.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b0675872",
      "audio": ""
    },
    {
      "text": "A 45-year-old obese man with type 2 diabetes reports 6 months of nighttime heartburn and sour taste, worsened by spicy foods and lying down. Antacids provide temporary relief. UGIE shows mild esophagitis. What's the best next step?",
      "options": [
        {
          "label": "A",
          "text": "Lifestyle modifications and a trial of proton pump inhibitors (PPIs)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Immediate Nissen fundoplication",
          "correct": false
        },
        {
          "label": "C",
          "text": "24-hour esophageal pH monitoring",
          "correct": false
        },
        {
          "label": "D",
          "text": "High-dose H2 receptor antagonists",
          "correct": false
        }
      ],
      "correct_answer": "A. Lifestyle modifications and a trial of proton pump inhibitors (PPIs)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Lifestyle modifications and a trial of proton pump inhibitors (PPIs)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Immediate Nissen fundoplication : This surgical intervention is considered in cases of GERD refractory to medical therapy or in patients who prefer surgery to long-term medication. It is not indicated as an initial step in the management of mild GERD.</li><li>\u2022 Option B. Immediate Nissen fundoplication</li><li>\u2022 Option C. 24-hour esophageal pH monitoring : This diagnostic tool is used to confirm the diagnosis of GERD in cases where the diagnosis is uncertain, especially in patients with non-erosive reflux disease (NERD), or to assess the effectiveness of acid-suppressive therapy. It is not indicated as an initial step in the management of a patient with confirmed GERD and esophagitis on UGIE.</li><li>\u2022 Option C. 24-hour esophageal pH monitoring</li><li>\u2022 Option D. High-dose H2 receptor antagonists : While H2 receptor antagonists can reduce acid production and provide symptomatic relief in GERD, PPIs are more effective in healing esophagitis and are preferred as the initial pharmacological therapy.</li><li>\u2022 Option D. High-dose H2 receptor antagonists</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The initial management of GERD with mild esophagitis includes lifestyle modifications and a trial of proton pump inhibitors. PPIs are preferred over H2 receptor antagonists due to their superior efficacy in healing esophagitis and relieving GERD symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e94d7b24",
      "audio": ""
    },
    {
      "text": "A 28-year-old man presents with dysphagia. He has a history of atopic dermatitis and seasonal allergies. An upper endoscopy is performed as seen in the image provided. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Reflux esophagitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Herpes simplex virus esophagitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Eosinophilic esophagitis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Candida esophagitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Eosinophilic esophagitis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091804.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Eosinophilic esophagitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 O ption A. Reflux esophagitis : Typically shows erythema, ulceration, or erosions, not the concentric rings as seen in the image.</li><li>\u2022 O</li><li>\u2022 ption A. Reflux esophagitis</li><li>\u2022 Option B. Herpes simplex virus esophagitis : Usually presents with multiple small, shallow ulcers.</li><li>\u2022 Option B. Herpes simplex virus esophagitis</li><li>\u2022 Option D. Candida esophagitis : Often visible as white plaques or lesions along the esophageal mucosa.</li><li>\u2022 Option D. Candida esophagitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The presence of esophageal concentric rings on endoscopy, especially in a patient with atopic history, is indicative of eosinophilic esophagitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fdfed33e",
      "audio": ""
    },
    {
      "text": "A 42-year-old immunocompromised male presents with odynophagia and retrosternal chest pain. His symptoms began abruptly a few days ago and have progressively worsened. An upper endoscopy reveals several shallow, small ulcers in the esophagus as shown in the image. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Reflux esophagitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytomegalovirus esophagitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Herpes simplex virus esophagitis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Candida esophagitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Herpes simplex virus esophagitis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091932.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Herpes simplex virus esophagitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Reflux esophagitis : More commonly presents with linear erosions and erythema rather than discrete shallow ulcers.</li><li>\u2022 Option A. Reflux esophagitis</li><li>\u2022 Option B. Cytomegalovirus esophagitis : Typically exhibits larger, deeper ulcers on endoscopy.</li><li>\u2022 Option B. Cytomegalovirus esophagitis</li><li>\u2022 Option D. Candida esophagitis : Usually visualized as white plaques or lesions along the esophageal mucosa, resembling cottage cheese.</li><li>\u2022 Option D. Candida esophagitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In an immunocompromised patient with acute odynophagia and endoscopic findings of shallow ulcers, herpes simplex virus esophagitis is the most likely diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c097637c",
      "audio": ""
    },
    {
      "text": "A 56-year-old male with a history of HIV/AIDS presents with dysphagia, odynophagia, and retrosternal chest pain. His CD4 count is 100 cells/mm\u00b3. An endoscopy is performed and the image provided shows linear white plaques along the esophagus. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Reflux esophagitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytomegalovirus esophagitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Herpes simplex virus esophagitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Candida esophagitis",
          "correct": true
        }
      ],
      "correct_answer": "D. Candida esophagitis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-092211.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Candida esophagitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Reflux esophagitis : Usually presents with erythematous mucosa and linear erosions rather than white plaques.</li><li>\u2022 Option A. Reflux esophagitis</li><li>\u2022 Option B. Cytomegalovirus esophagitis : Typically presents with large superficial ulcers on endoscopy, not white plaques.</li><li>\u2022 Option B. Cytomegalovirus esophagitis</li><li>\u2022 Option C. Herpes simplex virus esophagitis : Often presents with multiple small, shallow ulcers, not white plaques.</li><li>\u2022 Option C. Herpes simplex virus esophagitis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In an immunocompromised patient presenting with odynophagia and dysphagia, the finding of white plaques on endoscopy is diagnostic of Candida esophagitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96ad1619",
      "audio": ""
    },
    {
      "text": "A 50-year-old man with chronic epigastric pain relieved by antacids and frequent NSAID use presents with sudden severe \"tearing\" epigastric pain radiating to the back since 4 hours. Physical exam shows epigastric tenderness. Chest X-ray is normal. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Start a proton pump inhibitor and admit for observation.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Perform an urgent endoscopy.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Order an abdominal ultrasound to assess for gallstones.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Obtain a serum amylase and lipase.",
          "correct": false
        }
      ],
      "correct_answer": "B. Perform an urgent endoscopy.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Perform an urgent endoscopy.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Start a proton pump inhibitor and admit for observation : While PPIs are part of the management for peptic ulcer disease, the acute nature and severity of the patient's symptoms warrant immediate diagnostic evaluation to rule out complications like perforation or bleeding.</li><li>\u2022 Option A. Start a proton pump inhibitor and admit for observation</li><li>\u2022 Option C. Order an abdominal ultrasound to assess for gallstones : While gallstone disease can present with epigastric pain, the patient's history of chronic epigastric pain relieved by antacids and NSAID use strongly points towards peptic ulcer disease rather than biliary colic.</li><li>\u2022 Option C. Order an abdominal ultrasound to assess for gallstones</li><li>\u2022 Option D. Obtain a serum amylase and lipase : These tests are useful in diagnosing pancreatitis, which can present with epigastric pain radiating to the back. However, the patient's history and clinical presentation are more consistent with peptic ulcer disease.</li><li>\u2022 Option D. Obtain a serum amylase and lipase</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In a patient with sudden severe epigastric pain and a history suggestive of peptic ulcer disease, urgent endoscopy is critical to diagnose potential complications such as perforation or bleeding and to initiate appropriate therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9ad4de48",
      "audio": ""
    },
    {
      "text": "A 32-year-old woman presents to the clinic with a 4-day history of watery diarrhea, abdominal cramps, and nausea. She reports no recent travel, antibiotic use, or sick contacts. Her stool does not contain blood or mucus. She denies any fever or significant dietary changes prior to the onset of symptoms. Laboratory studies, including stool cultures, are negative for pathogens. A stool osmotic gap calculation shows a low value. Which of the following is the most likely mechanism of her diarrhea?",
      "options": [
        {
          "label": "A",
          "text": "Decreased absorption of nutrients due to mucosal damage",
          "correct": false
        },
        {
          "label": "B",
          "text": "Osmotic load from unabsorbed dietary substances",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased chloride secretion in the gut",
          "correct": true
        },
        {
          "label": "D",
          "text": "Motility disorder causing rapid intestinal transit",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased chloride secretion in the gut",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increased chloride secretion in the gut</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Decreased absorption of nutrients due to mucosal damage : This mechanism is more typical of inflammatory diarrhea, which often presents with fever, bloody diarrhea, and evidence of inflammation on laboratory tests.</li><li>\u2022 Option A. Decreased absorption of nutrients due to mucosal damage</li><li>\u2022 Option B. Osmotic load from unabsorbed dietary substances : Osmotic diarrhea occurs when non-absorbable substances in the diet draw water into the gut, characterized by a high stool osmotic gap.</li><li>\u2022 Option B. Osmotic load from unabsorbed dietary substances</li><li>\u2022 Option D. Motility disorder causing rapid intestinal transit : While rapid transit can contribute to diarrhea, it is not characterized by a low stool osmotic gap and is more commonly associated with conditions like irritable bowel syndrome.</li><li>\u2022 Option D. Motility disorder causing rapid intestinal transit</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Secretory diarrhea is characterized by increased electrolyte secretion, particularly chloride, into the gut, leading to watery stools. It is identified by a low stool osmotic gap and the absence of pathogenic organisms in stool cultures.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be276490",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman reports chronic diarrhea, bloating, fatigue, and unexplained weight loss, worsened by consuming gluten-containing foods. She has iron-deficiency anemia and low vitamin D levels. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Irritable Bowel Syndrome (IBS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inflammatory Bowel Disease (IBD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Celiac Disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gastric Ulcer",
          "correct": false
        }
      ],
      "correct_answer": "C. Celiac Disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Celiac Disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Irritable Bowel Syndrome (IBS) : While IBS can cause similar gastrointestinal symptoms, it does not lead to nutrient malabsorption or the specific nutrient deficiencies seen in this patient.</li><li>\u2022 Option A. Irritable Bowel Syndrome (IBS)</li><li>\u2022 Option B. Inflammatory Bowel Disease (IBD) : IBD, including Crohn's disease and ulcerative colitis, could cause similar symptoms and anemia, but the specific worsening with gluten-containing foods and the combination of deficiencies point more towards celiac disease.</li><li>\u2022 Option B. Inflammatory Bowel Disease (IBD)</li><li>\u2022 Option D. Gastric Ulcer : A gastric ulcer might cause pain and anemia due to bleeding, but it would not typically cause the nutrient malabsorption, diarrhea, and specific dietary trigger related to gluten intake.</li><li>\u2022 Option D. Gastric Ulcer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Chronic gastrointestinal symptoms that worsen with gluten ingestion, combined with iron-deficiency anemia and other signs of malabsorption, are suggestive of celiac disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da30e24f",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate initial test to evaluate this patient for celiac disease?",
      "options": [
        {
          "label": "A",
          "text": "Serum albumin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-tissue transglutaminase antibody (tTG-IgA)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stool fat content",
          "correct": false
        },
        {
          "label": "D",
          "text": "Colonoscopy with biopsy",
          "correct": false
        }
      ],
      "correct_answer": "B. Anti-tissue transglutaminase antibody (tTG-IgA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Anti-tissue transglutaminase antibody (tTG-IgA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Serum albumin : While low serum albumin can indicate malnutrition, it is not specific for celiac disease.</li><li>\u2022 Option A. Serum albumin</li><li>\u2022 Option C. Stool fat content : Elevated stool fat content can indicate malabsorption but is not specific for celiac disease and is less commonly used as an initial test.</li><li>\u2022 Option C. Stool fat content</li><li>\u2022 Option D. Colonoscopy with biopsy : While biopsy of the small intestine is the gold standard for diagnosing celiac disease, it is typically performed after positive serological testing.</li><li>\u2022 Option D. Colonoscopy with biopsy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In patients with symptoms suggestive of celiac disease, the anti-tissue transglutaminase antibody (tTG-IgA) test is the most appropriate initial investigation due to its high sensitivity and specificity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b052777",
      "audio": ""
    },
    {
      "text": "Which of the following medications is currently approved for the treatment of celiac disease?",
      "options": [
        {
          "label": "A",
          "text": "Glutenase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prednisone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dapsone",
          "correct": false
        },
        {
          "label": "D",
          "text": "There are no medications approved for the treatment of celiac disease; the only effective treatment is a strict gluten-free diet.z",
          "correct": true
        }
      ],
      "correct_answer": "D. There are no medications approved for the treatment of celiac disease; the only effective treatment is a strict gluten-free diet.z",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) There are no medications approved for the treatment of celiac disease; the only effective treatment is a strict gluten-free diet.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Glutenase : Enzyme supplements that break down gluten, known as glutenases, have been researched but are not yet approved for the treatment of celiac disease.</li><li>\u2022 Option A. Glutenase</li><li>\u2022 Option B. Prednisone : Corticosteroids like prednisone may be used in severe cases or for refractory celiac disease, but they are not a standard treatment for typical cases of celiac disease.</li><li>\u2022 Option B. Prednisone</li><li>\u2022 Option C. Dapsone : Dapsone is used for dermatitis herpetiformis, a skin manifestation of celiac disease, but not for treating the intestinal aspect of celiac disease itself.</li><li>\u2022 Option C. Dapsone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The cornerstone of managing celiac disease is a strict gluten-free diet, as there are currently no medications approved to treat the condition directly.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5da4b9b1",
      "audio": ""
    },
    {
      "text": "Which symptom aligns with Rome IV criteria for IBS?",
      "options": [
        {
          "label": "A",
          "text": "Pain relief post-bowel movement",
          "correct": true
        },
        {
          "label": "B",
          "text": "Discomfort and bloating",
          "correct": false
        },
        {
          "label": "C",
          "text": "No alarming symptoms",
          "correct": false
        },
        {
          "label": "D",
          "text": "Varied stool consistency",
          "correct": false
        }
      ],
      "correct_answer": "A. Pain relief post-bowel movement",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Pain relief post-bowel movement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Discomfort and bloating : While common in IBS, these alone do not fulfill the diagnostic criteria without the specific relationship to bowel movements.</li><li>\u2022 Option B. Discomfort and bloating</li><li>\u2022 Option C. No alarming symptoms : The absence of alarming symptoms is important in IBS diagnosis but, by itself, does not confirm the condition.</li><li>\u2022 Option C. No alarming symptoms</li><li>\u2022 Option D. Varied stool consistency : Changes in stool form and frequency are part of the criteria but need to be associated with abdominal pain for IBS diagnosis.</li><li>\u2022 Option D. Varied stool consistency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In diagnosing IBS, a key feature is recurrent abdominal pain that improves with defecation, per the Rome IV criteria. This distinguishes IBS from other gastrointestinal disorders.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "03c46a47",
      "audio": ""
    },
    {
      "text": "A 29-year-old woman has recurrent abdominal pain, fluctuating between diarrhea and constipation for 6 months. The pain often lessens post-defecation. No weight loss, bleeding, or anemia is present. What diagnosis fits the Rome IV criteria?",
      "options": [
        {
          "label": "A",
          "text": "Nocturnal diarrhea",
          "correct": false
        },
        {
          "label": "B",
          "text": "Food-induced pain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Abdominal pain with stool changes",
          "correct": true
        },
        {
          "label": "D",
          "text": "Constipation without pain",
          "correct": false
        }
      ],
      "correct_answer": "C. Abdominal pain with stool changes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Abdominal pain with stool changes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Nocturnal diarrhea : While diarrhea can be a symptom of IBS, nocturnal diarrhea is not specific to IBS and can be indicative of other conditions.</li><li>\u2022 Option A. Nocturnal diarrhea</li><li>\u2022 Option B. Food-induced pain : Food can trigger symptoms in IBS, but the Rome IV criteria specifically highlight the relationship between pain and defecation or stool changes.</li><li>\u2022 Option B. Food-induced pain</li><li>\u2022 Option D. Constipation without pain : IBS requires the presence of abdominal pain; constipation alone, without associated pain, does not meet the criteria for IBS.</li><li>\u2022 Option D. Constipation without pain</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The diagnosis of IBS according to the Rome IV criteria is based on recurrent abdominal pain associated with defecation and changes in stool frequency or form, not solely on the presence of bowel habit abnormalities like nocturnal diarrhea or constipation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb0bd705",
      "audio": ""
    },
    {
      "text": "Which of the following findings would be considered a \"red flag\" that suggests a need for further investigation beyond IBS?",
      "options": [
        {
          "label": "A",
          "text": "Alternating diarrhea and constipation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Abdominal bloating and gas",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nocturnal bowel movements",
          "correct": true
        },
        {
          "label": "D",
          "text": "Response to dietary changes",
          "correct": false
        }
      ],
      "correct_answer": "C. Nocturnal bowel movements",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Nocturnal bowel movements</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Alternating diarrhea and constipation : Common in IBS and not considered a red flag.</li><li>\u2022 Option A. Alternating diarrhea and constipation</li><li>\u2022 Option B. Abdominal bloating and gas : Typical symptoms of IBS, not red flags.</li><li>\u2022 Option B. Abdominal bloating and gas</li><li>\u2022 Option D. Response to dietary changes : Improvement with dietary changes supports an IBS diagnosis and is not a red flag.</li><li>\u2022 Option D. Response to dietary changes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In the evaluation of suspected IBS, nocturnal bowel movements are a red flag warranting further investigation to exclude organic diseases.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "907fad76",
      "audio": ""
    },
    {
      "text": "A 68-year-old man with chronic NSAID use presents with black tarry stools and vomiting bright red blood. The most immediate next diagnostic step is -",
      "options": [
        {
          "label": "A",
          "text": "Abdominal X-ray",
          "correct": false
        },
        {
          "label": "B",
          "text": "Esophagogastroduodenoscopy (EGD)",
          "correct": true
        },
        {
          "label": "C",
          "text": "CT angiography",
          "correct": false
        },
        {
          "label": "D",
          "text": "H. pylori stool antigen test",
          "correct": false
        }
      ],
      "correct_answer": "B. Esophagogastroduodenoscopy (EGD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Esophagogastroduodenoscopy (EGD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Abdominal X-ray: Abdominal X-ray is not sensitive or specific for diagnosing PUD and is not indicated for acute upper GI bleeding.</li><li>\u2022 Option A. Abdominal X-ray:</li><li>\u2022 Option C. CT angiography: CT angiography may be used when EGD does not identify the bleeding source, or if the bleeding is suspected to be from a lower GI source, which is not suggested in this case.</li><li>\u2022 Option C. CT angiography:</li><li>\u2022 Option D. H. pylori stool antigen test: It is a non-invasive test to diagnose H. pylori infection, a common cause of PUD, but it is not used for acute diagnosis or management of upper GI bleeding.</li><li>\u2022 Option D. H. pylori stool antigen test:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 EGD is the critical next step in diagnosing and managing a patient with suspected PUD bleeding, particularly when presenting with melena and hematemesis, and a history of NSAID use.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba8f21e4",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with peptic ulcer disease and hematemesis presents with tachycardia and low hemoglobin. After initial fluid resuscitation, the next step is to",
      "options": [
        {
          "label": "A",
          "text": "Discontinue aspirin and start a high-dose proton pump inhibitor (PPI) infusion.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Perform immediate surgery to control the source of bleeding.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer a single dose of intravenous vitamin K.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Schedule an elective esophagogastroduodenoscopy (EGD) within the next 24 hours.",
          "correct": false
        }
      ],
      "correct_answer": "A. Discontinue aspirin and start a high-dose proton pump inhibitor (PPI) infusion.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Discontinue aspirin and start a high-dose proton pump inhibitor (PPI) infusion.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Immediate surgery is not the first-line treatment for PUD bleeding and is reserved for cases where endoscopic treatment fails or if the patient is hemodynamically unstable after resuscitation.</li><li>\u2022 Option B.</li><li>\u2022 Option C. Vitamin K is given for reversal of vitamin K antagonist therapy or in cases of severe coagulopathy; it is not indicated as a routine initial treatment for PUD bleeding.</li><li>\u2022 Option C.</li><li>\u2022 Option D. While an EGD is necessary for the diagnosis and potential treatment of PUD bleeding, it should be performed urgently in a patient with active bleeding and hemodynamic instability, not electively within the next 24 hours.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The immediate management of acute PUD bleeding includes discontinuation of aspirin and initiation of a high-dose PPI infusion to reduce acid secretion and promote clot stability.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2db97119",
      "audio": ""
    },
    {
      "text": "A 70-year-old female with systemic sclerosis, chronic iron deficiency anemia, and melena has an EGD showing multiple longitudinal stripes of red mucosa alternating with normal mucosa in the stomach. The most likely diagnosis is -",
      "options": [
        {
          "label": "A",
          "text": "Gastric antral vascular ectasia (GAVE)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Peptic ulcer disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Portal hypertensive gastropathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gastritis due to Helicobacter pylori infection",
          "correct": false
        }
      ],
      "correct_answer": "A. Gastric antral vascular ectasia (GAVE)",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-110039.png"
      ],
      "explanation": "<p><strong>Ans. A) Gastric antral vascular ectasia (GAVE)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Peptic ulcer disease: It is usually presents with focal ulcers rather than longitudinal stripes of erythema.</li><li>\u2022 Option B. Peptic ulcer disease:</li><li>\u2022 Option C. Portal hypertensive gastropathy: It is associated with liver disease and portal hypertension, not systemic sclerosis, and usually does not present with the striped pattern seen on endoscopy.</li><li>\u2022 Option C. Portal hypertensive gastropathy:</li><li>\u2022 Option D. Gastritis due to Helicobacter pylori infection: It is typically diffusely erythematous and does not have the characteristic striped pattern seen in GAVE.</li><li>\u2022 Option D. Gastritis due to Helicobacter pylori infection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The endoscopic appearance of \"watermelon stomach\" is indicative of Gastric Antral Vascular Ectasia (GAVE), especially in patients with systemic sclerosis presenting with chronic anemia and gastrointestinal bleeding.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "faab5fc8",
      "audio": ""
    },
    {
      "text": "A 48-year-old man with GERD and hypertension presents with hematemesis after heavy drinking and forceful retching. Examination shows mild epigastric tenderness and normal liver function tests. The most likely diagnosis is-",
      "options": [
        {
          "label": "A",
          "text": "Esophageal varices",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gastric antral vascular ectasia (GAVE)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peptic ulcer disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mallory-Weiss tear",
          "correct": true
        }
      ],
      "correct_answer": "D. Mallory-Weiss tear",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Mallory-Weiss tear</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Esophageal varices: It could be a cause of hematemesis but are usually associated with signs of chronic liver disease, which this patient does not have.</li><li>\u2022 Option A. Esophageal varices:</li><li>\u2022 Option B. Gastric antral vascular ectasia (GAVE) : It is typically seen as a chronic condition associated with iron deficiency anemia and is characterized by distinctive endoscopic findings, not typically related to acute episodes of retching.</li><li>\u2022 Option B. Gastric antral vascular ectasia (GAVE)</li><li>\u2022 Option C. Peptic ulcer disease: It could present with hematemesis but is less likely in the absence of abdominal pain and a history of forceful retching.</li><li>\u2022 Option C. Peptic ulcer disease:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mallory-Weiss tear is a cause of hematemesis in the context of heavy alcohol consumption and forceful retching, especially in the absence of chronic liver disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5d621d9f",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with severe abdominal pain, bloody diarrhea, and fever after eating at a new seafood restaurant 3 days ago. Examination shows diffuse abdominal tenderness. The most likely diagnosis is",
      "options": [
        {
          "label": "A",
          "text": "Inflammatory Bowel Disease (IBD)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Infectious Colitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ischemic Colitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Irritable Bowel Syndrome (IBS)",
          "correct": false
        }
      ],
      "correct_answer": "B. Infectious Colitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Infectious Colitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Inflammatory Bowel Disease (IBD): IBD usually presents with a more prolonged history of abdominal pain and bloody diarrhea and may have systemic symptoms such as weight loss.</li><li>\u2022 Option A. Inflammatory Bowel Disease (IBD):</li><li>\u2022 Option C. Ischemic Colitis: Ischemic Colitis often affects older patients with known cardiovascular risks and presents with sudden onset abdominal pain and bloody diarrhea without significant preceding events.</li><li>\u2022 Option C. Ischemic Colitis:</li><li>\u2022 Option D. Irritable Bowel Syndrome (IBS): IBS is characterized by chronic abdominal pain and altered bowel habits without significant fever or bloody stools, typically in the absence of an infectious trigger.</li><li>\u2022 Option D. Irritable Bowel Syndrome (IBS):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Infectious colitis is characterized by acute onset of bloody diarrhea following a potential exposure to contaminated food.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7115b90",
      "audio": ""
    },
    {
      "text": "A 78-year-old man with chronic kidney disease and aortic stenosis presents with maroon-colored stools and iron deficiency anemia. Colonoscopy shows multiple small, flat, red lesions in the cecum. The most likely diagnosis is",
      "options": [
        {
          "label": "A",
          "text": "Colonic diverticulosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ischemic colitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Angiodysplasia of the colon",
          "correct": true
        },
        {
          "label": "D",
          "text": "Colorectal carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "C. Angiodysplasia of the colon",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Angiodysplasia of the colon</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Colonic diverticulosis: Colonic diverticulosis can cause bleeding but typically presents with larger, sac-like protrusions rather than flat, red lesions.</li><li>\u2022 Option A. Colonic diverticulosis:</li><li>\u2022 Option B. Ischemic colitis: Ischemic colitis usually presents with abdominal pain and bloody diarrhea, often in patients with a history of vascular disease or risk factors for ischemia.</li><li>\u2022 Option B. Ischemic colitis:</li><li>\u2022 Option D. Colorectal carcinoma: Colorectal carcinoma might present with iron deficiency anemia and rectal bleeding but typically shows as a mass lesion on colonoscopy, not as small, flat lesions.</li><li>\u2022 Option D. Colorectal carcinoma:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 To identify angiodysplasia of the colon in an elderly patient with chronic kidney disease and aortic stenosis, presenting with intermittent, painless rectal bleeding and iron deficiency anemia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab6a4afe",
      "audio": ""
    },
    {
      "text": "A 28-year-old man with a history of intermittent abdominal pain and non-bloody diarrhea undergoes a colonoscopy, which shows segmental areas of inflammation interspersed with normal mucosa, primarily affecting the ileum and ascending colon. A biopsy reveals transmural inflammation and non-caseating granulomas. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Crohn's Disease",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ulcerative Colitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Irritable Bowel Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Celiac Disease",
          "correct": false
        }
      ],
      "correct_answer": "A. Crohn's Disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Crohn's Disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Ulcerative Colitis : Characterized by continuous mucosal inflammation starting from the rectum and extending proximally, without granulomas.</li><li>\u2022 Option B. Ulcerative Colitis</li><li>\u2022 Option C. Irritable Bowel Syndrome : A functional gastrointestinal disorder without the inflammatory or structural changes seen in Crohn's Disease.</li><li>\u2022 Option C. Irritable Bowel Syndrome</li><li>\u2022 Option D. Celiac Disease : Involves inflammation and villous atrophy in the small intestine triggered by gluten ingestion, not typically presenting with granulomas or segmental inflammation.</li><li>\u2022 Option D. Celiac Disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The presence of \"skip lesions,\" transmural inflammation, and granulomas on biopsy are indicative of Crohn's Disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de599267",
      "audio": ""
    },
    {
      "text": "Sacroiliitis is a common extraintestinal manifestation associated with ?",
      "options": [
        {
          "label": "A",
          "text": "Crohn's Disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ulcerative Colitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both Crohn's Disease and Ulcerative Colitis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Neither, this is unrelated to IBD",
          "correct": false
        }
      ],
      "correct_answer": "C. Both Crohn's Disease and Ulcerative Colitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Both Crohn's Disease and Ulcerative Colitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Crohn's Disease : While sacroiliitis can be associated with Crohn's, it is not exclusive to this form of IBD.</li><li>\u2022 Option A. Crohn's Disease</li><li>\u2022 Option B. Ulcerative Colitis : Similarly, Ulcerative Colitis can also present with sacroiliitis, but it is not the sole IBD associated with this condition.</li><li>\u2022 Option B. Ulcerative Colitis</li><li>\u2022 Option D. Neither, this is unrelated to IBD : Incorrect, as sacroiliitis is well-documented as an extraintestinal manifestation of both Crohn's Disease and Ulcerative Colitis.</li><li>\u2022 Option D. Neither, this is unrelated to IBD</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Sacroiliitis can be an extraintestinal manifestation of both Crohn's Disease and Ulcerative Colitis, highlighting the systemic inflammatory involvement in IBD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f24350e4",
      "audio": ""
    },
    {
      "text": "A 40-year-old male with mild Ulcerative Colitis limited to the rectum (ulcerative proctitis) is seeking treatment options. What is the most appropriate initial therapy?",
      "options": [
        {
          "label": "A",
          "text": "Oral corticosteroids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Topical 5-aminosalicylic acid (5-ASA)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Systemic immunosuppressants",
          "correct": false
        },
        {
          "label": "D",
          "text": "Colectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. Topical 5-aminosalicylic acid (5-ASA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Topical 5-aminosalicylic acid (5-ASA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Oral corticosteroids : Generally reserved for more severe or extensive disease not responsive to 5-ASA agents.</li><li>\u2022 Option A. Oral corticosteroids</li><li>\u2022 Option C. Systemic immunosuppressants : Used for moderate to severe disease or in patients who do not respond to first-line therapies.</li><li>\u2022 Option C. Systemic immunosuppressants</li><li>\u2022 Option D. Colectomy : Considered a last resort, typically for severe, refractory disease or when there's a high risk of cancer.</li><li>\u2022 Option D. Colectomy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Topical 5-ASA agents are the first-line treatment for mild ulcerative proctitis due to their efficacy and safety profile.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "833d5918",
      "audio": ""
    },
    {
      "text": "A 29-year-old female with moderate to severe Ulcerative Colitis not responding to oral 5-ASA therapy is considering her treatment options. Which of the following is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Initiate oral prednisone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Increase the dose of oral 5-ASA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add topical corticosteroids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Surgical colectomy",
          "correct": false
        }
      ],
      "correct_answer": "A. Initiate oral prednisone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Initiate oral prednisone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Increase the dose of oral 5-ASA : This approach is unlikely to be effective in moderate to severe cases not responding to initial 5-ASA therapy.</li><li>\u2022 Option B. Increase the dose of oral 5-ASA</li><li>\u2022 Option C. Add topical corticosteroids : While useful in some cases, topical corticosteroids may not provide sufficient control for moderate to severe disease.</li><li>\u2022 Option C. Add topical corticosteroids</li><li>\u2022 Option D. Surgical colectomy : Considered in cases of refractory disease, complications, or increased cancer risk, but not typically the next step after 5-ASA failure.</li><li>\u2022 Option D. Surgical colectomy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Oral corticosteroids are the next step in management for moderate to severe Ulcerative Colitis not responding to 5-ASA therapy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7f154c00",
      "audio": ""
    },
    {
      "text": "A 35-year-old male with a known diagnosis of Crohn's disease is diagnosed with toxic megacolon. He is hemodynamically stable but shows signs of systemic toxicity. What is the most appropriate initial management for this condition?",
      "options": [
        {
          "label": "A",
          "text": "Immediate surgical intervention",
          "correct": false
        },
        {
          "label": "B",
          "text": "Broad-spectrum antibiotics and bowel rest",
          "correct": true
        },
        {
          "label": "C",
          "text": "Administration of antidiarrheal agents",
          "correct": false
        },
        {
          "label": "D",
          "text": "High-dose corticosteroids and intravenous hydration",
          "correct": false
        }
      ],
      "correct_answer": "B. Broad-spectrum antibiotics and bowel rest",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Broad-spectrum antibiotics and bowel rest</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Immediate surgical intervention : Indicated in cases of perforation, massive bleeding, or failure of medical management.</li><li>\u2022 Option A. Immediate surgical intervention</li><li>\u2022 Option C. Administration of antidiarrheal agents : Contraindicated in toxic megacolon as it may exacerbate colonic dilation and the risk of perforation.</li><li>\u2022 Option C. Administration of antidiarrheal agents</li><li>\u2022 Option D. High-dose corticosteroids : May be used to reduce inflammation in conjunction with other supportive measures, but not alone.</li><li>\u2022 Option D. High-dose corticosteroids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Initial management of toxic megacolon involves bowel rest, IV hydration, and broad-spectrum antibiotics, with surgical intervention reserved for complications or failure of conservative treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b5937ee4",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a history of atrial fibrillation presents to the emergency department with sudden onset of severe abdominal pain out of proportion to physical findings. His heart rate is irregular, and an abdominal examination reveals mild tenderness without rebound or guarding. Which of the following is the most likely cause of his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Acute mesenteric ischemia due to arterial embolism",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chronic mesenteric ischemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mesenteric venous thrombosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nonocclusive mesenteric ischemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute mesenteric ischemia due to arterial embolism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute mesenteric ischemia due to arterial embolism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Chronic mesenteric ischemia : Typically presents with postprandial pain and weight loss due to fear of eating, developing over a longer time.</li><li>\u2022 Option B. Chronic mesenteric ischemia</li><li>\u2022 Option C. Mesenteric venous thrombosis : Often has a more gradual onset and may be associated with hypercoagulable states, not sudden and severe pain.</li><li>\u2022 Option C. Mesenteric venous thrombosis</li><li>\u2022 Option D. Nonocclusive mesenteric ischemia : Occurs in low-flow states like heart failure or sepsis, and while this patient has AFib, there's no mention of a low-flow state.</li><li>\u2022 Option D. Nonocclusive mesenteric ischemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Acute abdominal pain in a patient with atrial fibrillation suggests acute mesenteric ischemia due to arterial embolism, requiring prompt diagnosis and treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4cd2d31f",
      "audio": ""
    },
    {
      "text": "A 72-year-old man with COPD presents with diarrhea, abdominal cramping, and fever after recent antibiotics. His stool is watery with 5-6 bowel movements per day. What is the most appropriate diagnostic test to confirm the suspected diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Stool culture for enteric pathogens",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stool enzyme immunoassay for Clostridium difficile toxins",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sigmoidoscopy to visualize the colonic mucosa",
          "correct": false
        },
        {
          "label": "D",
          "text": "Abdominal ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "B. Stool enzyme immunoassay for Clostridium difficile toxins",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Stool culture for enteric pathogens: Is useful for identifying bacterial causes of diarrhea other than C. difficile, which is less likely given the patient's recent antibiotic use.</li><li>\u2022 Option A. Stool culture for enteric pathogens:</li><li>\u2022 Option C. Sigmoidoscopy can visualize colonic mucosal damage: Associated with severe cases of C. difficile infection but is not a first-line diagnostic tool due to its invasiveness and the availability of less invasive tests.</li><li>\u2022 Option C. Sigmoidoscopy can visualize colonic mucosal damage:</li><li>\u2022 Option D. Abdominal ultrasound: An abdominal ultrasound is not specific for diagnosing C. difficile infection and is more useful for evaluating other causes of abdominal pain and complications of infections.</li><li>\u2022 Option D. Abdominal ultrasound:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Stool enzyme immunoassay for C. difficile toxins is the most appropriate initial diagnostic test.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "550e5239",
      "audio": ""
    },
    {
      "text": "A 65-year-old female with a recent history of hospitalization for urinary tract infection treated with antibiotics presents with diarrhea and abdominal pain. The presence of which of the following in stool would most likely confirm the diagnosis of Clostridium difficile colitis?",
      "options": [
        {
          "label": "A",
          "text": "Blood",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leukocytes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Clostridium difficile toxin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ova and parasites",
          "correct": false
        }
      ],
      "correct_answer": "C. Clostridium difficile toxin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Blood: Blood in the stool can indicate various gastrointestinal conditions, including infections, inflammatory bowel disease, and colorectal cancer, but is not specific for C. difficile colitis.</li><li>\u2022 Option A. Blood:</li><li>\u2022 Option B. Leukocytes: Leukocytes in the stool suggest inflammation in the gastrointestinal tract, which can be seen in infectious colitis, inflammatory bowel disease, and other conditions, but is not specific for C. difficile infection.</li><li>\u2022 Option B. Leukocytes:</li><li>\u2022 Option D. Ova and parasites: The presence of ova and parasites in the stool indicates a parasitic infection, which is a different etiology from C. difficile colitis, typically caused by bacteria.</li><li>\u2022 Option D. Ova and parasites:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of Clostridium difficile toxin in stool is the key diagnostic marker for C. difficile colitis, particularly in patients with recent antibiotic use and symptoms of diarrhea and abdominal pain.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ebad520f",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman is diagnosed with moderate Clostridium difficile colitis. She has a history of penicillin allergy. Which of the following is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Metronidazole orally",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vancomycin orally",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fidaxomicin orally",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intravenous immunoglobulin",
          "correct": false
        }
      ],
      "correct_answer": "B. Vancomycin orally",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Metronidazole orally: Metronidazole orally was previously a standard treatment for C. difficile infection but is now generally reserved for mild cases or when first-line therapies are not available, due to its lower efficacy compared to vancomycin and fidaxomicin for moderate to severe infections.</li><li>\u2022 Option A.</li><li>\u2022 Metronidazole orally:</li><li>\u2022 Option C. Fidaxomicin orally: Fidaxomicin orally is another effective treatment for C. difficile colitis and could be considered a first-line therapy. However, it is often reserved for cases where there is a high risk of recurrence or for severe infections due to its higher cost.</li><li>\u2022 Option C.</li><li>\u2022 Fidaxomicin orally:</li><li>\u2022 Option D. Intravenous immunoglobulin: Intravenous immunoglobulin is used in severe, complicated cases, particularly with evidence of systemic toxicity or in recurrent infections not responding to standard therapies. It is not typically used as first-line therapy for moderate C. difficile colitis.</li><li>\u2022 Option D.</li><li>\u2022 Intravenous immunoglobulin:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The initial treatment of choice for moderate Clostridium difficile colitis, especially in patients with a penicillin allergy, is oral vancomycin. This therapy is preferred over metronidazole due to its superior efficacy in moderate to severe infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e8d58faa",
      "audio": ""
    },
    {
      "text": "A 58-year-old man presents with intermittent, painless rectal bleeding and small amounts of bright red blood. His history includes hypertension and a low-fiber diet. Physical and abdominal examinations are unremarkable, with no hemorrhoidal disease noted. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hemorrhoids",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diverticulosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ischemic colitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Colorectal cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Diverticulosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hemorrhoids: Hemorrhoids could cause painless rectal bleeding, but the absence of hemorrhoidal disease on rectal examination makes this less likely.</li><li>\u2022 Option A. Hemorrhoids:</li><li>\u2022 Option C. Ischemic colitis: Ischemic colitis typically presents with abdominal pain and sometimes bloody diarrhea, not just isolated, painless rectal bleeding.</li><li>\u2022 Option C. Ischemic colitis:</li><li>\u2022 Option D. Colorectal cancer: Colorectal cancer could present with rectal bleeding, but it is less likely to be intermittent and painless, and other symptoms such as weight loss or a change in bowel habits are often present.</li><li>\u2022 Option D. Colorectal cancer:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Diverticulosis is a common cause of intermittent, painless rectal bleeding in older adults, particularly those on a low-fiber diet, in the absence of hemorrhoidal disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "54d3d351",
      "audio": ""
    },
    {
      "text": "A 58-year-old woman presents with intermittent, painless rectal bleeding, but normal physical and rectal examination. What is the most appropriate next step to establish the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Anoscopy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Colonoscopy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Barium enema",
          "correct": false
        },
        {
          "label": "D",
          "text": "CT scan of the abdomen",
          "correct": false
        }
      ],
      "correct_answer": "B. Colonoscopy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Anoscopy: Is a useful tool for examining the anal canal and lower rectum but is limited in scope and would not be adequate for evaluating the entire colon, which is necessary given the patient's symptoms and age.</li><li>\u2022 Option A. Anoscopy:</li><li>\u2022 Option C. Barium enema: Is a radiographic exam used to visualize the colon and rectum. While it can detect abnormalities, it is less sensitive than colonoscopy and does not allow for biopsy.</li><li>\u2022 Option C. Barium enema:</li><li>\u2022 Option D. CT scan of the abdomen: Can provide detailed images of the abdominal organs, but it is not the best initial test for direct evaluation of the colon's inner lining and for performing biopsies of suspicious lesions.</li><li>\u2022 Option D. CT scan of the abdomen:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Colonoscopy is the most appropriate diagnostic test for a patient presenting with intermittent, painless rectal bleeding and a normal physical examination, allowing for comprehensive evaluation and biopsy of the colon and rectum.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "712d3f01",
      "audio": ""
    },
    {
      "text": "A 55-year-old man presents with left lower quadrant abdominal pain, low-grade fever, and a change in bowel habits to loose stools. His history includes hypertension, and examination reveals tenderness and slight guarding in the left lower quadrant. What is the most likely diagnosis ?",
      "options": [
        {
          "label": "A",
          "text": "Acute appendicitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diverticulitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ischemic colitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urinary tract infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Diverticulitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Acute appendicitis: Acute appendicitis typically presents with pain that starts around the umbilicus and then localizes to the right lower quadrant, not the left, and is associated with rebound tenderness, which is not described in this case.</li><li>\u2022 Option A. Acute appendicitis:</li><li>\u2022 Option C. Ischemic colitis: Ischemic colitis can cause abdominal pain and changes in bowel habits, but it is more often associated with risk factors such as cardiovascular disease, and the presentation can vary more widely than the classic presentation of diverticulitis.</li><li>\u2022 Option C. Ischemic colitis:</li><li>\u2022 Option D. Urinary tract infection: Urinary tract infection may cause abdominal discomfort, but it is more commonly associated with urinary symptoms such as dysuria, frequency, and urgency, and does not typically cause localized left lower quadrant pain or changes in bowel habits.</li><li>\u2022 Option D. Urinary tract infection:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Diverticulitis typically presents with left lower quadrant pain, fever, and altered bowel habits in adults, corresponding with the location of sigmoid diverticula. Top of Form</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3497f939",
      "audio": ""
    },
    {
      "text": "In the assessment of a patient suspected to have diverticulitis, imaging reveals a localized abscess adjacent to the sigmoid colon. According to the modified Hinchey classification, how should this case of diverticulitis be classified?",
      "options": [
        {
          "label": "A",
          "text": "Stage Ia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage Ib",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stage II",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stage III",
          "correct": false
        }
      ],
      "correct_answer": "C. Stage II",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Stage II</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Stage Ia: Stage Ia involves mild clinical diverticulitis without the presence of an abscess or other complications.</li><li>\u2022 Option A. Stage Ia:</li><li>\u2022 Option B. Stage Ib: Stage Ib is not a recognized category in the modified Hinchey classification.</li><li>\u2022 Option B. Stage Ib:</li><li>\u2022 Option D. Stage III: Stage III diverticulitis is characterized by a generalized purulent peritonitis, which is a more severe condition than a localized abscess.</li><li>\u2022 Option D. Stage III:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 According to the modified Hinchey classification for diverticulitis, Stage II is characterized by the presence of a localized abscess</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dcb6d1ca",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman with confirmed mild acute diverticulitis and no signs of systemic infection is stable and has no comorbidities. What is the most appropriate initial management for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Intravenous antibiotics and hospital admission",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral antibiotics and outpatient follow-up",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immediate surgical consultation for colectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endoscopic evaluation within 24 hours",
          "correct": false
        }
      ],
      "correct_answer": "B. Oral antibiotics and outpatient follow-up",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Oral antibiotics and outpatient follow-up</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Intravenous antibiotics and hospital admission: Are typically reserved for patients with severe diverticulitis, signs of systemic infection, hemodynamic instability, or significant comorbidities that may complicate the course of the disease.</li><li>\u2022 Option A. Intravenous antibiotics and hospital admission:</li><li>\u2022 Option C. Immediate surgical consultation for colectomy: Is generally considered in cases of complicated diverticulitis with conditions such as perforation, obstruction, fistula, or failure of medical management.</li><li>\u2022 Option C. Immediate surgical consultation for colectomy:</li><li>\u2022 Option D. Endoscopic evaluation within 24 hours: Is not typically indicated in the acute management of diverticulitis due to the risk of perforation and is usually avoided during the acute phase of the disease.</li><li>\u2022 Option D. Endoscopic evaluation within 24 hours:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A mild acute diverticulitis in a stable patient without comorbidities or signs of systemic infection can be initially managed with oral antibiotics and outpatient follow-up, reserving more invasive interventions for complicated cases or those with severe presentations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "25fbcb95",
      "audio": ""
    }
  ]
}